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Abstract

T cells are critical players in adaptive immunity. They migrate throughout the body
scanning the lymph nodes for antigen, then migrate to an infection site to help clear
pathogen. Migrating T cells use multiple receptors and adhesion proteins to migrate to
and enter different tissues. While the cell surface molecules involved in T cell motility
are well understood, less is known about intracellular signaling pathways involved in T
cell migration. PKCθ and CARMA1 signal downstream of TCR activation to induce NFκB activation. However, the roles of PKCθ and CARMA1 in other T cell functions are
unknown. In this study we investigate the roles of PKCθ and CARMA1 in regulating T
cell migration. We found that CARMA1 deficiency led to defective regulation of cell
surface adhesion molecules, increased migration speed of activated T cells in vitro, and
mislocalization of the actin regulatory ERM proteins. In contrast, PKCθ deficiency did
not affect the regulation of adhesion molecules or the migration of T cells. However
PKCθ-/- T cells also showed mislocalization of ERM proteins. Although CARMA1 is
directly phosphorylated downstream of PKCθ following TCR activation, our data show
iii

that CARMA1 likely regulates T cell migration in a PKCθ independent manner.

We also investigated the role of PKCθ in immunity to infection with the intracellular
bacteria Francisella tularensis. PKCθ is important in immunity to some pathogens, but
in certain cases, PKCθ deficiency is not important or can even be protective. T cells are
crucial in F. tularensis immunity, with multiple subsets playing an important role. We
found that PKCθ deficiency was protective against LVS, an F. tularensis strain highly
infectious in mice, with PKCθ-/- mice surviving longer than the WT mice upon LVS
infection. We found the organs of the infected PKCθ-/- mice had a smaller percentage of
CD4+ T cells and a larger percentage of CD4-CD8- T cells compared to WT mice. These
results suggest that PKCθ-/- mice are protected against F. tularensis infection and that
PKCθ may contribute to the development of different T cell populations which contribute
to protective immunity against F. tularensis infection.
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Introduction
T cells
The immune system is important for protecting an organism against disease. There are
two layers of protection: the innate immune system and the adaptive immune system.
The innate immune system provides a non-specific but immediate response. The
adaptive immune system provides a response that is specific to a pathogen, but it takes
time to generate this response. T cells are important players in the adaptive immune
response. They are a diverse group of cells that perform many different roles in
immunity. They can act as “helpers”, termed CD4 helper T cells, helping to activate B
cells, other T cells, or other immune cells such as macrophages. They can also act as
“killers”, CD8 or cytotoxic T cells, directly killing infected cells.

T cells originate from hematopoietic stem cells and develop in the thymus. Mature T
cells then leave the thymus into circulation via the bloodstream. These unactivated, or
naïve, T cells move throughout the body scanning the lymph nodes for antigen presented
on major histocompatibility complex molecules (MHC) that will bind to their T cell
receptors (TCRs). To ensure that there will be a T cell that can bind to a wide variety of
pathogenic antigen, TCRs are very diverse; only a few naïve T cells circulating at any
time can bind a given antigen. Dendritic cells (DCs) collect antigen from a site of
infection and then migrate to the nearest lymph node where they are scanned by T cells
moving through. As lymph nodes are the location where DCs and T cells interact to
initiate a T cell response, it is very important that the T cells are able to migrate
efficiently to and through each lymph node to increase the chance of a productive
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encounter.

When a T cell encounters a dendritic cell presenting cognate antigen, the T cell is
activated via the TCR and begins to proliferate and produce cytokines. The activated T
cells can then migrate to affected sites and assist in fighting the infection. At the
infection site the T cells fight the infection as either helper T cells or cytotoxic T cells.
When the infection is cleared, most of the T cells die, but some of these T cells become
memory T cells that can persist long after an infection is cleared and can then respond
more quickly if there is a secondary infection with the same pathogen (U.H. von Andrian
& Mackay, 2000).

T cell homing and migration
Circulating T cells must be able to move from the blood into lymph nodes to scan for
antigen, or into other tissues once activated. What tissues the T cells migrate into is
regulated by the cell surface molecules expressed on the T cells and is called “homing”
(Butcher & Picker, 1996). The T cells must adhere to the wall of the blood vessel by
binding to endothelial cells (ECs) using adhesion molecules so that they can migrate into
the tissue. Binding to ECs and migrating into tissue involves two major adhesion events
(Figure 1). The first adhesion event involves a group of molecules called selectins.
Selectins bind to sialyl-LewisX-like sugars (U.H. von Andrian & Mackay, 2000). The
adhesion of the selectin to its ligand tethers the cell to the endothelium, and the shear
stress from the blood flow causes the cell to start rolling. The rolling T cells encounter
chemokines on the endothelium, and when these chemokines bind to their receptors
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Figure 1. Naïve T cells adhere to the endothelium in the blood stream in a multi-step
process before entering the lymph node. L-selectin binds to PNAd on the endothelial cell,
slowing the T cell and causing it to roll. CCR7 ligand (CCL21) binds to CCR7, leading
to signaling that activates the αLβ2 (LFA-1) integrin on the T cell so it can bind to ICAM
on the endothelial cell. The T cell is arrested, and can now migrate into the lymph node
(Förster, Davalos-Misslitz, & Rot, 2008).

3

expressed on T cells, integrins on the T cells become activated. Integrin activation leads
to the second adhesion event and the integrins on the T cell bind to adhesion molecules
on the endothelium, arresting the cell. The arrested cell can then migrate into the tissue
(U.H. von Andrian & Mackay, 2000).

The tissue that a T cell homes to is determined by the selectin and selectin ligands,
chemokine receptors, and integrins expressed on the T cell and endothelium lining the
tissue. There are three types of selectins involved in leukocyte migration: L-selectin, Eselectin, and P-selectin. L-selectin (CD62L) is expressed on most leukocytes, including
naïve T cells, but is down-regulated on activated and memory T cells (Kansas, 1996). Lselectin binds to sulphated sialyl-LewisX-like sugars, called peripheral node addressin
(PNAd). PNAd sugars are found on the high endothelial venules (HEV) of lymph nodes,
and so T cells expressing L-selectin will home to lymph nodes (Marelli-Berg, Cannella,
Dazzi, & Mirenda, 2008). E-selectin is expressed on endothelial cells in response to
inflammatory signals, such as IL-1 or TNF-α (Kansas, 1996). P-selectin ligand 1 (PSGL1), CD43, and CD44 are all molecules expressed on T cells, particularly Th1 cells, that
have been shown to bind to E-selectin and help mediate migration into inflamed tissue,
particularly in the skin (Hirata et al., 2000; M. Matsumoto et al., 2007; Nácher et al.,
2011). P-selectin is expressed by platelets and endothelial cells, and may be expressed
very early in an inflammatory response because it is stored within granules in the cell
(Kansas, 1996). P-selectin binds to PSGL-1 on T cells to mediate activated T cell
migration into inflammatory sites.
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Chemokines are cytokines that can activate and induce movement in leukocytes. T cells
can express a variety of chemokine receptors to help the cells home to different tissues. A
chemokine that is highly expressed on HEVs is CCL21 (SLC), and when CCL21 binds to
its receptor CCR7 on T cells, CCR7 signaling activates the integrins on the T cell (Ulrich
H von Andrian & Mempel, 2003). CCL21 and CCL19 (ELC), another agonist for CCR7,
are also expressed within the lymph nodes and contribute to T cell migration within the
lymph nodes. Other chemokines are also found on HEVs, such as CXCL12, which some
memory T cells use to enter lymph nodes, as memory T cells express the chemokine
receptor CXCR4, which binds CXCL12, instead of CCR7 (Scimone et al., 2004). Some
chemokines, such as CXCL9 and CCL2, are expressed on HEVs only when there is
inflammation (Cyster, 2005). The expression of other chemokine receptors will direct T
cells to other tissues. CCR4, CCR8, and CCR10 expression directs T cells to the skin,
where their ligands are expressed, while CCR9 expression leads to migration to the
lamina propria, and others such as CCR5 and CXCR3 direct T cells to sites of
inflammation (Bromley, Mempel, & Luster, 2008).

Integrins are important not only for arrest in the bloodstream, but also for migration
within tissues. Integrins are composed of two chains, an α and a β chain, and there are 24
known αβ pairs in vertebrates (Luo, Carman, & Springer, 2007). On T cells integrins are
in an inactive state and have little affinity for their ligands until they are activated through
signaling from the TCR or chemokine receptors (Kinashi, 2005). Integrins bind to
endothelial immunoglobulins, including intercellular adhesion molecule 1 (ICAM-1),
mucosal addressin-cell adhesion molecule type 1 (MAdCAM-1), and vascular-cell
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adhesion molecule 1 (VCAM-1). An important integrin for T cell migration to lymph
nodes is LFA-1 (αLβ2), which binds ICAM-1 and is involved in arresting the cells in the
bloodstream and in transmigration into the lymph nodes (Andrew et al., 1998; DeNucci
& Mitchell, 2009; Warnock, Askari, Butcher, & von Andrian, 1998). LPAM (α4β7) is
important for migration to mesenteric lymph nodes (MLNs) and Peyer's patches (PPs) as
well as inflamed gut tissue; LPAM binds to MAdCAM-1, which is largely expressed in
the gut (DeNucci & Mitchell, 2009). MAdCAM-1 has also been shown to bind to Lselectin, indicating that it can function in the rolling stage of the adhesion cascade (Berg,
McEvoy, Berlin, & Bargatze, 1993). The integrin α4β1 binds to VCAM-1, which is
involved in trafficking to many tissues, including bone marrow (Koni et al., 2001) and
the CNS (Engelhardt & Ransohoff, 2005), and is upregulated in response to inflammation
(DeNucci & Mitchell, 2009).

ICAM-1 and VCAM-1 are both expressed within the lymph node, but T cell motility
within lymph nodes is not strictly integrin dependent (DeNucci & Mitchell, 2009); T cells
lacking LFA-1 were shown to migrate in lymph nodes similarly to WT T cells in an in
vivo study (Woolf et al., 2007). However it was shown that interaction between ICAM-1
on a dendritic cell and LFA-1 on a T cell is important for strong signaling with CD8+ T
cells and the generation of memory T cells, so integrins do play an important role in the
initiation of the T cell response within the lymph node (Scholer, Hugues, Boissonnas,
Fetler, & Amigorena, 2008).

The combination of these different receptors and adhesion molecules expressed on the T
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cells determines the destination of the cell. Naïve T cells rely on CD62L, CCR7, and
LFA-1 to enter the lymph nodes. When a T cell is activated, the expression of adhesion
molecules and chemokine receptors is changed. As T cells activate and become effector
T cells (TEFF), they downregulate CCR7 and CD62L, so they no longer circulate through
lymph nodes (Mora & von Andrian, 2006). TEFF also have increased expression of
molecules that will direct them to other tissues, such as E-selectin ligands including
CD44, and chemokine receptors such as CCR4 and CCR10 (Marelli-Berg et al., 2008).
There are also differences in expression of receptors and adhesion molecules in memory
T cells. Effector memory T cells (TEM) have similar expression to TEFF, but central
memory T cells (TCM) do express CCR7 and CD62L, and so are able to home to lymph
nodes as well as peripheral tissues (Mora & von Andrian, 2006). This differential
expression of chemokine receptors and adhesion molecules on different T cells ensures
that the T cells will migrate to the tissue where they are needed, either to respond to an
infection or to antigen presented in the lymph nodes.

T cell polarization and motility
T cells must migrate between the endothelial cells of the blood vessel wall and through
the basement membrane, made up of a matrix of collagen and other fibers, to arrive at
their target tissues. Therefore they must adopt a more flexible form to move through the
small spaces created by the matrix mesh. Furthermore, the cells need to generate force in
order to push through this matrix towards DCs within lymph nodes or towards infection
sites. Chemokines play a major role in this process; aside from activating the integrins
and inducing chemotaxis, they also induce changes in the cytoskeleton and polarization
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of the cell (Sanchez-Madrid & del Pozo, 1999).

T cells are polarized into two distinct regions: the leading edge and the uropod (del Pozo,
Sánchez-Mateos, Nieto, & Sánchez-Madrid, 1995) (Figure 2). The microtubule
organizing center (MTOC) localizes to the uropod and the actin cytoskeleton is
redistributed throughout the cell; the actin cycle providing the extension and contraction
that moves the cell forward (Sánchez-Madrid & Serrador, 2009). Many cell surface
receptors and other molecules are also polarized in motile T cells. Chemokine receptors
localize to the leading edge and are responsible for the chemotaxis of the cell (SanchezMadrid & del Pozo, 1999). Adhesion molecules localize to the uropod, including ICAMs
and L-selectin (Sánchez-Madrid & Serrador, 2009). Another group of molecules that
localize to the uropod are the ezrin/radixin/moesin (ERM) proteins. These closely related
proteins are actin regulatory proteins and can bind the actin to the plasma membrane,
associating with transmembrane proteins such as CD43 and CD44 (Tsukita, Yonemura, &
Tsukita, 1997). Moesin is the most abundant of these proteins in T cells (SchwartzAlbiez, Merlini, Spring, Möller, & Koretz, 1995). This linking of the actin filaments to
the plasma membrane is important for ensuring continuous movement of the T cell
(Sanchez-Madrid & del Pozo, 1999).

T cell activation and protein localization
Protein localization is not only important for T cell motility, but also for T cell activation.
When a T cell interacts with an antigen-presenting cell, a junction called the
immunological synapse (IS) is formed. Different components are localized to distinct
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Figure 2. A polarized T cell migrating, with localization of adhesion molecules,
chemokine receptors, and cytoskeletal components localized to the leading edge and
uropod (Sanchez-Madrid & del Pozo, 1999).

9

regions of the IS called supramolecular activation clusters (Dustin, 2009). The TCR and
costimulatory molecule CD28 localize to the IS as well as adhesion molecules like LFA1 and cytoskeletal components including talin and F-actin. Signaling molecules
downstream of the TCR also localize to the IS upon TCR activation. One such molecule
is protein kinase C (PKC)θ (Monks, Kupfer, Tamir, & Barlow, 1997).

PKCθ is in the novel PKC (nPKC) family of PKCs, which do not require Ca2+ for
activation (Hayashi & Altman, 2007). PKCθ is found mainly in T cells, as well as
platelets and muscle cells. Following TCR activation, hydrolysis of PIP2 generates DAG,
which activates PKCθ (Isakov, 2002). PKCθ has been shown to be involved in several
signaling pathways downstream of the TCR. PKCθ was shown to lead to the activation
of AP-1(Baier-Bitterlich et al., 1996), and PKCθ along with calcinurin leads to the
activation of JNK and NF-AT (Werlen, Jacinto, Xia, & Karin, 1998). In 2000, PKCθ
was found to be involved in NF-κB activation (Coudronniere, Villalba, Englund, &
Altman, 2000; X. Lin, O’Mahony, Mu, Geleziunas, & Greene, 2000). These are all
pathways very important to T cell proliferation and survival. AP1, NF-AT, and NF-κB
are all involved in IL-2 production, which is important for T cell homeostasis (Altman,
Isakov, & Baier, 2000; Marrack et al., 2000). Mice that are PKCθ-deficient appear
normal and are fertile, and there is no apparent defect in T cell development in the
thymus or in numbers of T cells in the thymus, lymph nodes, and spleen (Sun et al.,
2000). However, it was shown that T cells from mice lacking PKCθ have impaired IL-2
production (Sun et al., 2000).
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Downstream of PKCθ following TCR activation is CARMA1. CARMA1 (also called
CARD11) is a membrane-associated guanylate kinase (MAGUK) that also contains a
caspase-associated recruitment domain (CARD), so that it can both associate with the
cytoplasmic membrane and bind to other molecules containing CARD domains (Blonska
& Lin, 2009) (Figure 3). CARMA1 is largely only expressed in hematopoietic cells.
CARMA1 plays a key role in NF-κB activation in T cells; it is required for the
recruitment of PKCθ to the immune synapse (Wang et al., 2002, 2004). Upon TCR
activation, CARMA1 is phosphorylated in the linker domain by activated PKCθ, and
once phosphorylated can recruit the other components necessary for signaling, including
Bcl10, IKKβ, and MALT1, to the IS (Che et al., 2004; R. Matsumoto et al., 2005; Wang
et al., 2004) Protein phosphatase 2A (PP2A) dephosphorylates CARMA1 at the site of
PKCθ-dependent phosphorylation, acting as a negative regulator for NF-κB activation
(Eitelhuber et al., 2011). CARMA1 is also shown to be involved in JNK2 activation
(Blonska & Lin, 2009). CARMA1-/- T cells develop normally in the thymus, but
activation is severely impaired, with reduced proliferation and IL-2 production and
defective upregulation of CD25, CD69, and CD44 (Hara et al., 2003).

PKCθ and CARMA1 roles in T cell immune responses
PKCθ has different roles in immunity depending on the type of T cell response. PKCθ-/mice have been shown to have reduced Th2 responses; they were protected from an
allergic hypersensitivity response in an inhaled allergen model, and the Th2 response to a
helminth infection was greatly reduced (Marsland, Soos, Späth, Littman, & Kopf, 2004).
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Figure 3. Domains of the CARMA1 protein.

12

The same mice, however, were able to produce an effective response to Leishmania
major, which requires Th1 cells and IFNγ. In another study, using an airway
inflammation model, it was shown that PKCθ is required for a good Th2 response, but
that while the Th1 response was slowed initially, PKCθ was not required and IFNγ
production was normal (Salek-Ardakani, So, Halteman, Altman, & Croft, 2004). These
studies indicate that PKCθ is more critical for Th2 responses than Th1.

PKCθ was also shown to be important for CD8+ effector T cells; PKCθ-/- CD8+ T cells
did not survive as well as wild-type T cells (Barouch-Bentov et al., 2005). However,
other studies have shown that PKCθ is not required for an effective CD8+ response to
viral infections (Giannoni, Lyon, Wareing, Dias, & Sarawar, 2005; Marsland et al., 2005).
The role that PKCθ plays in any given immune response appears to vary greatly, even
among those that appear to require a similar response. PKCθ is required for the
development of experimental allergic encephalomyelitis (EAE), which depends on a Th1
and Th17 response (Salek-Ardakani, So, Halteman, Altman, & Croft, 2005). PKCθ is
also required for graft-versus-host disease (GVHD), but not for graft-versus-leukemia
(GVL) or an effective immune response to Listeria monocytogenes (Valenzuela et al.,
2009). PKCθ is also shown to be important for the production of IFNγ; in Toxoplasma
gondii infection PKCθ-/- mice succumbed to infection with reduced IFNγ production,
while in another study PKCθ-/- mice were partially protected from cerebral malaria,
which was attributed to reduced Th1 type cytokine production, including IFNγ (Nishanth
et al., 2010; Ohayon et al., 2010). These various studies show that the role of PKCθ in T
cell responses is varied, and will require further study to be fully understood.
13

CARMA1, like PKCθ, is shown to have varying importance in different types of T cell
responses. CARMA1 appears to play a more important role in the development of some
T cell subsets than in others; CARMA1-/- mice exhibited defective development of Tregs,
and reduced memory CD4+ T cells in the periphery, but showed normal development of
NKT cells (Medoff et al., 2009). In a murine model of allergic airway inflammation,
CARMA1 was found to be required for an inflammatory response, and CARMA1-/- mice
had reduced Th2-type cytokines (Medoff et al., 2006). In a later study where CARMA1
was deleted from T cells after activation, it was shown that CARMA1 is also important
for reactivation in memory T cells; these mice did not develop airway inflammation in
response to a secondary challenge (Ramadas et al., 2011). The defect in Th2 responses is
likely due to a decrease in JunB and GATA3; a recent study reveals that CARMA1
regulates Th2 cytokine production through expression of JunB and GATA3 (Blonska,
Joo, Zweidler-McKay, Zhao, & Lin, 2012).

Francisella tularensis
Francisella tularensis is a facultative intracellular bacterium that causes the disease
tularemia. There are four subspecies of F. tularensis: tularensis, holarctica, mediasiatica,
and novicida, the first two of which are known to cause disease in humans (Sjöstedt,
2006). Subspecies tularensis is much more virulent in humans than holarctica and is
more frequently fatal if untreated (Oyston, Sjostedt, & Titball, 2004). The low dose of F.
tularensis that is needed to cause tularemia, as well as the fact that it can be transmitted
by an airborne route, has made it an agent of interest as a potential biological weapon
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(Oyston et al., 2004). In the 1950's a live vaccine strain (LVS) was developed from a
strain of subspecies holarctica, and it is frequently used in F. tularensis research because
while it has low virulence in humans, it is very virulent in mice. The potential use of F.
tularensis as a biological weapon has increased the interest in researching this pathogen,
particularly in developing effective vaccines to protect against attacks.

Immune response to Francisella tularensis
F. tularensis is resistant to some of the usual mechanisms of innate immunity. It is
resistant to the lethal components of complement, and in fact can use the opsonizing
components to enter and infect cells (Cowley & Elkins, 2011). Francisella LPS has also
been found to not be recognized by human or murine immune systems, and so it does not
induce a pro-inflammatory response. However, there is still an innate response mounted
against Francisella; TLR2 and MyD88 have both been shown to play a role in early
cytokine production in response to Francisella infection.

F. tularensis can infect many different types of cells, but they mainly infect macrophages.
Once infection occurs, the bacteria are able to quickly escape the phagosome and
replicate freely within the cytoplasm (Oyston et al., 2004). The bacteria eventually
induce apoptosis in the macrophages by inducing the release of cytochrome c from the
mitochondria and the activation of caspases 9 and 3 (Lai & Sjostedt, 2003). If the
infected macrophages are activated by either IFNγ or TNFα, they are able to control the
bacterial replication (Sjöstedt, 2006). Pro-inflammatory and Th1-type cytokines,
including IFNγ, TNFα, IL-6, and IL-1β, are very important for controlling F. tularensis
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infection, but they are not present in detectable levels until 48 hours after infection at the
earliest, and this can often be too late for protective immunity (Cowley & Elkins, 2011).
The cytokines that seem to be the most important are IFNγ and TNFα; the absence of
either makes mice susceptible to any dose of LVS. IL-17A and IL-12 are also important
to a lesser degree to clear infection (Cowley & Elkins, 2011).

The role of T cells in F. tularensis immunity
Several different immune cell types are important for controlling and clearing a F.
tularensis infection. Neutrophils, mast cells and NK cells play a role in controlling
Francisella infection, though none are essential (Cowley & Elkins, 2011).

B and T

cells, however, seem to be the important players for effective immune response and
protection from repeat infections. The role of B cells is not completely understood, but it
seems B cells are less important in primary F. tularensis infections, and play a more
important role in secondary infections that is not entirely antibody-mediated (Karen L
Elkins, Cowley, & Bosio, 2007).

T cells are required to clear an infection of F. tularensis; while mice lacking T cells are
able to control a low dose LVS infection at first, they eventually succumb to the infection
after about 1 month (K L Elkins, Rhinehart-Jones, Nacy, Winegar, & Fortier, 1993; K L
Elkins, Rhinehart-Jones, Culkin, Yee, & Winegar, 1996). Either CD4+ or CD8+ T cells
are individually able to clear an infection (Yee, Rhinehart-Jones, & Elkins, 1996).
Another population of T cells, CD4− CD8− NK1.1− TCRαβ+ Thy1.2+ T cells, or “DN” T
cells, is also able to control F. tularensis infection but not clear it; the mice survive for

16

months with a chronic infection (Cowley et al., 2005). DN T cells do seem play an
important role in anti-Francisella immunity; they are found in greater numbers in
pulmonary infections than in intradermal, and they help produce IL-17A along with
CD4+ and CD8+ T cells (Cowley, Meierovics, Frelinger, Iwakura, & Elkins, 2010).

IL-17A was shown to be very important in F. tularensis infection for helping to regulate
the Th1 responses needed to control the infection (Y. Lin et al., 2009). CD4+, CD8+, and
DN T cells all also produce IFNγ and TNFα to control the growth of F. tularensis in
macrophages (Cowley & Elkins, 2003). A γδ+ T cell population in humans can also help
control F. tularensis infection; γ9δ2 T cell numbers increase when exposed to F.
tularensis antigen, and the γ9δ2 T cells produce both IFNγ and TNFα (Poquet et al.,
1998; Rowland et al., 2012). Together, these data show that T cells are very important for
an immune response to F. tularensis and that a variety of populations can play a role in
protection against Francisella tularensis infection.

Purpose
While a lot is known about the cell surface molecules and receptors involved in T cell
migration, not much is known about the intracellular signaling pathways that may be
involved in T cell migration. PKCθ and CARMA1 are both well established as signaling
mediators downstream of TCR activation, but their potential role in other T cell
functions, including migration, is unknown. In this thesis we investigate their roles in
different aspects of T cell migration. We also investigate the role of PKCθ in the immune
response to Francisella tularensis.
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Methods
Mice
C57BL/6 mice, B6.Ly5.1 and B6.PKCθ-deficient mice were from Jackson Laboratories
(Bar Harbor, ME). B6.CARMA1-deficient mice were a kind gift of Dr. Marisa Alegre
from the University of Chicago. All mice were bred and/or maintained in a specific
pathogen-free condition in barrier facilities (Albuquerque, NM) and conform to the
principles outlined by the Animal Welfare Act and the National Institutes of Health
guidelines.

Reagents and antibodies
Antibodies were purchased from the following: Fluorescent conjugated α-CD4, αCD62L, and α-CD25 were from eBiosciences (San Diego, CA); fluorescent conjugated
α-CD44, α-CD4, α-CD19, α-CD11b, α-CD4, α-CD8, α-CD62L were from Biolegend
(San Diego, CA); α-tubulin was from Thermo Fisher (Lab Vision, Fremont CA); Santa
Cruz Biotechnology (Santa Cruz, CA); α-moesin and α-pERM were from Cell Signaling
Technology (Beverly, MA); and α-CD43 antibody S11 was produced in the laboratory of
Dr. Anne Sperling at the University of Chicago. CCL21 was from Peprotech (Rocky Hill,
NJ), ICAM-Fc from R&D Systems (Minneapolis, MN), CFSE and Collagenase 1 were
from Invitrogen (Carlsbad, CA). IL-2 was from the NCI Preclinical Repository, α-CD3
antibody 2C11and α-CD28 antibody PV1 from BioXCell (West Lebanon, NH), and
pertussis toxin was from Sigma-Aldrich (St. Louis, MO). Secondary fluorescently tagged
antibodies for immunofluorescence were purchased from Jackson Immunoresearch (West
Grove, PA).
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T cell isolation and activation
Primary T cells from murine lymph nodes were purified by non-adherence to nylon wool,
which results in >85% CD3+ T cells, as described (Sperling et al., 1995). Briefly, lymph
nodes from mice were removed, cells dissociated, and then incubated on nylon wool.
After 30 minutes, non-adherent cells were collected and used for assays. CD4+ T cells
were isolated using CD4+ T cell Isolation Kit II according to manufacturer’s protocols
(Miltenyi Biotec, Auburn, CA). For activated cells, primary T cells were isolated by
nylon wool activated on plates coated for 2 hours with 0.5ug/ml 2C11 and 1.0ug/ml PV1.
10U/ml IL2 was added to activating cells after 24 hours. Activated cells were used
between days 2-9 and cells were split at days 3-4 as needed.

Immunofluorescence Staining and Microscopy
Purified primary murine T cells were placed on poly-L-lysine coated coverslips and then
fixed for 20 min in 3% paraformaldehyde (PFA) in PBS, quenched with 50 mM
NH4Cl/PBS, permeabilized for 1 min with 0.3% Triton-X100, and blocked with a PSG
solution (PBS, 0.01% saponin, 0.25% aqueous cold fish gelatin, and 0.02% NaN3 [all
from Sigma, St. Louis, MO]). Fixed cells were incubated with primary antibodies for 1
hour, washed 5 times with PSG, and incubated for 30 minutes with fluorochrome labeled
secondary antibodies. Coverslips were washed 5 times with PSG, rinsed with ddH2O, and
then mounted on slides with Prolong Gold (Invitrogen, Carlsbad, CA). Cells were
visualized using a 63xDIC Oil objective on a Zeiss Axioplan 2 MOT upright LSM510
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Confocal microscope. Images were obtained using the Zeiss LSM 510 Image Acquisition
software and analyzed with the Zeiss LSM Image Browser. Cells were analyzed for
intensity of the fluorescent signal at multiple points on the cell and the intensity of the
signal at the uropod was compared to that at the leading edge.

In vitro Live Cell Imaging
50 mm glass bottom culture dishes (MatTek, Ashland, MA) were coated with
6ug/ml Recombinant Intercellular Adhesion Molecule-1 (ICAM-1Fc) in PBS for 2
hours, blocked for 1 hour with 2.5% bovine serum albumin (BSA) in PBS, then stored at
4°C in PBS until use. Isolated primary T cells were incubated at 37°C for 1hour with
300ng/ml CCL21 on ICAM-1 coated dishes, and then imaged. Activated T cells (7-9 days
post activation) were isolated using a Ficoll gradient to remove dead cells, and then
incubated at 37°C for 15 min with 300ng/ml CCL21 on ICAM-1 coated dishes and
imaged. T cells treated with pertussis toxin were incubated for 2 hours in 0.5μg/ml
pertussis toxin, then treated with CCL21 before being placed on the ICAM-1 coated dish
for imaging. T cells were imaged every 2 seconds for 10 minute intervals on the
Olympus DSU Spinning Disk Confocal/Stereology IX-81 inverted microscope with a
60xDIC Water objective and live cell incubation system at 37°C with 70% humidity and
5% CO2. Cells were individually tracked on Slidebook 5.0 software (Intelligent Imaging
Innovations Inc., Denver, CO, USA). Cells were tracked for 5-7 minutes each, and only
cells that were continuously in frame and had no collisions with other cells were tracked.
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Inoculation of mice with Francisella tularensis
1x105 cfu or 1x104 cfu LVS was delivered intranasally in 50μl to mice sedated with
isoflurane. The animals were then observed for mortality, or sacrificed at indicated days
for analysis.

Processing of infected mouse organs
Animals infected with Francisella tularensis were sacrificed at day 7 post infection, and
lymph nodes, spleens, lungs, and livers removed. Lymph nodes were dissociated under
Nitex mesh in media, then cells in media were recovered. Spleens were dissociated under
Nitex mesh, cells in the media were recovered, then red blood cells (RBC) were lysed.
Remaining cells were recovered. Livers were dissociated under Nitex mesh, cells in the
media were recovered, RBC lysed, and cells were centrifuged through a 35% Percoll
gradient. Lungs were minced into small pieces, then digested with 150 U/ml Collagenase
1 for one hour, and cells were centrifuged through a 44%/66% Percoll gradient.

Flow Cytometry
Primary and activated T cells (taken between 2 and 9 days post activation) and total
leukocytes were incubated with fluorescent antibodies for 20 min at 4°C. Data were
acquired using the BD LSRFortessa. Data were analyzed using FlowJo software (Tree
Star Inc., Ashland, OR).

Statistical analysis
All graphs were generated and statistics were done using Graphpad Prism 5 (Graphpad
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Software, Inc., La Jolla, CA, USA). Unpaired or paired Student two-tailed t tests were
used as indicated in figure legends. Error bars represent SEM.
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RESULTS
1. The role of CARMA1 in T cell migration
CARMA1 is very important for recruiting signaling components such as Bcl10 and
MALT1 to the TCR upon activation, and mediating signal transduction pathways leading
to NF-κB activation, resulting in increased T cell survival, proliferation, and IL-2
production. However, nothing is known about whether CARMA1 might regulate other
aspects of T cell function, including T cell migration. We hypothesized that CARMA1
would also be important for regulating T cell migration.

CARMA1 regulates the expression of migration markers upon T cell activation.
T cells lacking CARMA1 have impaired activation, and have been shown to have
reduced proliferation, poor IL-2 production, and defective up-regulation of the cell
surface markers CD25, CD69, and CD44, which are associated with activation (Hara et
al., 2003). However, nothing is known about whether CARMA1 might regulate other
aspects of T cell function such as T cell migration. T cell migration is critically dependent
on cell surface expression of selectins, chemokine receptors, integrins, and other
molecules that act to adhere T cells to endothelial cells to mediate T cell entry into tissues
such as lymph nodes and inflammatory sites.

To determine whether CARMA1 might regulate T cell migration, we first investigated
whether CARMA1 also regulates the expression of cell surface markers involved in T
cell migration. We focused particularly CD62L and CD44, which are both differentially
expressed in naïve and activated T cells and important for T cell homing. CD62L is
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highly expressed on naïve T cells and helps them home to lymph nodes; upon T cell
activation CD62L is down-regulated so that the T cells will no longer home to the lymph
nodes and instead migrate to peripheral tissues. On the other hand, CD44 is not highly
expressed in naïve T cells, but is upregulated in activated T cells to help them migrate
into inflamed tissue where E-selectin, which binds CD44, is expressed.

To examine the expression of CD44 and CD62L on activated T cells, we isolated T cells
from WT and CARMA1-/- mice using nylon wool, which results in >85% CD3+ T cells,
including both CD4+ and CD8+ T cells. We stained T cells isolated from WT and
CARMA1-/- mice with Carboxyfluorescein succinimidyl ester (CFSE), a fluorescent dye
taken up into cells which can track cell division. CFSE stained cells evenly split the dye
between daughter cells during cell division so proliferation can be tracked by flow
cytometry as the signal is diluted (Lyons & Parish, 1994). We activated CFSE stained
WT and CARMA1-/- T cells via antibody to CD3, the component of the TCR that induces
the signaling downstream of TCR activation, and to CD28, which is a co-stimulatory
molecule that enhances the signaling from the TCR (Acuto & Michel, 2003). This
combination of anti-CD3 and anti-CD28 leads to activation of multiple signaling
pathways, including NF-κB and JNK, inducing T cell proliferation and IL-2 production.

It has previously been shown that CARMA1-/- T cells do not proliferate as well as WT T
cells (Hara et al., 2003). Thus, we added exogenous IL-2 to help compensate for the
deficient IL-2 production of the CARMA1-/- T cells. We found that without the
supplemental IL-2 the CARMA1-/- T cells only survive for 2-3 days in culture (data not
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shown), however with additional IL-2 survival improved. To assess effects of CARMA1
on the expression of T cell migration markers, we isolated activated WT and CARMA1-/T cells at three days post activation. At day 3, we analyzed the T cells using flow
cytometry for proliferation by assessing the level of CFSE dilution. In addition, we also
labeled the cells for CD44 and CD62L expression. We had previously assessed
proliferation at days 1 and 2 post activation and found little proliferation by CFSE
dilution at these time points (data not shown). By the third day after activation the WT T
cells showed significant proliferation and regulation of expression of cell surface
molecules (See Figure 4). Thus we determined that day 3 was the optimal day to analyze
differences between activated WT and CARMA1-/- T cells.

Upon activation, T cells upregulate CD44, which acts as a ligand for E-selectin which
directs the T cells to inflamed tissue (Nácher et al., 2011). Previously Hara et al. showed
that there was a defect in upregulation of CD44 in CARMA1-/- T cells 24 hours after
activation. Similar to Hara et al., we found that 3 days after activation CARMA1-/- T
cells did not upregulate CD44 to the same extent as WT T cells (Figure 4A,B). The
difference in upregulation was not due to impaired proliferation however; while the
CARMA1-/- T cells did not proliferate as well as the WT T cells, even CARMA1-/- T cells
that had proliferated still showed defective CD44 upregulation compared with WT T cells
(Figure 4A).

When T cells are activated, they also downregulate CD62L, which normally enables
homing of T cells to the lymph nodes (Jung, Gallatin, Weissman, & Dailey, 1988). We
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Figure 4. CARMA1-/- T cells have defective upregulation of CD44 compared with WT T
cells. Naive T cells isolated from lymph nodes were stained with 5μM CFSE and
activated with α-CD3 and α-CD28 for 3 days before analysis. Activated T cells were
stained with fluorescent α-CD44 prior to analysis with flow cytometry. (A) Decreased
CFSE intensity indicates cells that have proliferated. Arrows indicate the approximate
average CD44 intensity. (B) Histogram showing CD44 intensity. Proliferated CARMA1/T cells have lower expression of CD44 than the proliferated WT T cells.
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found that while the majority of the proliferated WT T cells had down-regulated CD62L,
most of the CARMA1-/- T cells were still CD62Lhi (Figure 5A,B). As we saw with
CD44, the lack of down-regulation was not simply due to the impaired proliferation; even
the CARMA-/- T cells that had proliferated, most still showed CD62Lhi expression
profile. These data show that CARMA1 plays a role in regulating the change in
expression of migration markers upon T cell activation that is independent of
proliferation, regulating CD62L downregulation and CD44 upregulation, likely leading to
changes in the migration capacity of T cells upon activation.

CARMA 1 controls the motility of activated T cells in vitro
CARMA1-/- T cells show major defects in activation, including defective regulation of
the expression of cell surface molecules involved in T cell migration. This led us to
investigate whether CARMA1-/- T cells have defective motility as well. To do this, we
used an in vitro migration assay to assess the effect of CARMA1 on T cell motility. We
activated WT T cells and CARMA1-/- T cells as previously described and seven to nine
days post activation we isolated the activated T cells with Ficoll gradient to remove dead
cells. We then imaged the activated T cells in the presence of CCL21 on dishes coated
with ICAM-1 to induce migration. T cells that adhered to the dish were captured by
time-lapse in 2 second increments for up to 10 minutes and videos of cell motility were
analyzed for multiple parameters (Figure 6). Individual cells were tracked for 5 to 7
minutes; cells that moved out of the field of view or collided with other cells were not
counted.

27

Figure 5. CARMA1-/- T cells show defective downregulation of CD62L. Naive T cells
isolated from lymph nodes were stained with 5μM CFSE and activated with α-CD3 and
α-CD28 for 3 days before analysis. Activated T cells were stained with fluorescent αCD62L prior to analysis with flow cytometry. (A) Decreased CFSE intensity indicates
cells that have proliferated. The areas indicated with the red square show cells that have
proliferated and have downregulated CD62L. Only 19% of CARMA1-/- T cells
proliferated and downregulated CD62L compared with 75% of WT T cells. (B)
Histogram showing CD62L intensity.
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Figure 6. Activated WT and CARMA1-/- T cells migrating on ICAM-1. WT and
CARMA1-/- T cells were activated with α-CD3 and α-CD28 7-9 days prior to the in vitro
migration assay. T cells were suspended in media with 300ng/ml CCL21 and placed on
dishes coated with ICAM-1. T cells were imaged in a 37ºC 5% CO2 humidified chamber
starting 15 minutes after being placed in the chamber, taking time-lapse images in 2
second increments for up to 10 minutes. One frame of a video is shown; arrows indicate
migrating cells.
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We found that surprisingly, the activated CARMA1-/- T cells had a much higher average
speed at 22.1 μm/min than the WT T cells at 14.2 μm/min, as well as a higher maximum
speed (57 μm/min vs. 46 μm/min) (Figure 7A,B). We then analyzed the chemotactic
index, the distance a cell moved in a given direction divided by the total displacement of
the cell (Moghe, Nelson, & Tranquillo, 1995). While CARMA1-/- T cells moved at a
higher velocity than WT T cells, we found no difference in chemotactic index between
WT and CARMA1-/- T cells (Figure 7C). As we found differences in migration of
activated WT and CARMA1-/- T cells, we also took naïve WT and CARMA1-/- T cells
purified from mouse lymph nodes on nylon wool and analyzed their migration on ICAM1 in the presence of CCL21. Interestingly, there was no difference in average or
maximum speed or chemotactic index between naïve WT T cells and CARMA1-/- T cells
(Figure 8). These data indicate that CARMA1 does play a role in regulating the motility
of activated T cells, but not naïve T cells.

CARMA1 does not affect T cell dependence on CCR7 signaling for activated T cell
motility in vitro
Naïve T cells have been shown to require CCL21 activation of CCR7 to induce adhesion
and motility on ICAM-1 in vitro (Stachowiak, Wang, Huang, & Irvine, 2006). Activated
T cells are not as dependent on CCR7, since signaling through the TCR complex upon
activation can also enhance the binding of LFA-1 to ICAM-1 (Van Kooyk, Van De Wielvan Kemenade, Weder, Kuijpers, & Figdor, 1989). However it is unknown whether the
signaling through CCR7 might still play a role in migration of activated T cells. Our
previous results in Figures 7 and 8 showing that CARMA1 plays a role in regulating the
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Figure 7. Activated CARMA1-/- T cells have a higher average and maximum speed than
activated WT T cells. Videos of activated WT and CARMA1-/- T cells, as shown in Figure
6, were analyzed and individual cells tracked for 5-7 minute intervals. (A) CARMA1-/- T
cells had an average speed of 22 μm/min which was much higher than WT T cells at 14
μm/min. (B) CARMA1-/- T cells had a higher maximum speed than WT T cells, at 57
μm/min compared to 46 μm/min. (C) Chemotactic index is defined as distance migrated
from starting point / total displacement; there was no significant difference between
CARMA1-/- T cells and WT T cells. Each dot represents a single cell; plots show data
from 3 experiments. *** indicates p< 0.0001. Differences were considered statistically
significant with p<0.05.
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Figure 8. Naive CARMA1-/- and WT T cells migrate similarly on ICAM-1. Naïve WT
and CARMA1-/- T cells were isolated and suspended in media with 300ng/ml CCL21 and
placed on dishes coated with ICAM-1. T cells were imaged in a 37ºC 5% CO2
humidified chamber starting 1 hour after being placed in the chamber, taking time-lapse
images in 2 second increments for up to 10 minutes. Average speed (A), maximum speed
(B), and chemotactic index (C) were determined. No significant difference was seen for
any of these parameters.
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motility of activated but not naïve T cells suggests that CARMA1 may play differential
roles in regulating T cell migration, possibly due to differences in CCR7-dependent
versus CCR7-independent migration.

To determine whether CARMA1 played a role directly in CCR7-driven T cell motility,
we tested the role of CARMA1 in CCR7 mediated T cell migration by using the in vitro
motility assay described in Figure 6. We activated WT and CARMA1-/- T cells as
previously described and at 7-9 days post activation purified the live T cells and assayed
their motility on ICAM-1. To test the role of CCL21, we assayed the motility of
activated WT and CARMA1-/- T cells in the absence of CCL21. We found that WT and
CARMA1-/- T cells both still adhered and were motile in the absence of CCL21 (data not
shown). However, the WT T cells had a lower average speed than in the presence of
CCL21, migrating at 9.9 μm/min down from 14.2 μm/min (Figure 9A).

Likewise,

CARMA1-/- T cells migrated with a lower average speed in the absence of CCL21 than
when CCL21 was present, migrating at 15.2 μm/min down from 22.1 μm/min (Figure
9A). While both WT and CARMA1-/- T cells had decreased migration speed in the
absence of CCL21, CARMA1-/- T cells still migrated faster than the WT T cells. These
data indicate that activated WT T cells and CARMA1-/- T cells are both partially
dependent on CCL21 for migration on ICAM-1.

We also asked whether the in vitro motility in our assay were due to chemokine receptor
signaling. Chemokine receptors belong to the 7 trans-membrane spanning G-protein
coupled receptors (GPCRs). To test whether the effects of CCL21 were through
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Figure 9. Activated WT and CARMA1-/- T cells are partially dependent on CCL21 and
CCR7 signaling for migration on ICAM-1. WT and CARMA1-/- T cells were activated
with α-CD3 and α-CD28 7-9 days prior to the in vitro migration assay. T cells were
imaged on dishes coated with ICAM-1 in a 37ºC 5% CO2 humidified chamber starting 15
minutes after being placed in the chamber, taking time-lapse images in 2 second
increments for up to 10 minutes. Videos of activated WT and CARMA1-/- T cells were
analyzed and individual cells tracked for 5-7 minute intervals. (A) WT and CARMA1-/T cells were imaged either in media with 300ng/ml CCL21 (+CCL21) or in media with
no CCL21 (-CCL21). Both WT and CARMA1-/- T cells had slower average speeds in the
absence of CCL21. (B) WT and CARMA1-/- T cells were either treated with 0.5μg/ml
pertussis toxin (+Ptx) or imaged without treatment (Control). Both conditions were
imaged in media with 300ng/ml CCL21. WT and CARMA1-/- T cells both moved with a
slower average speed following Ptx treatment than the untreated T cells. **: p=0.0006,
***: p<0.0001. Differences were considered statistically significant with p<0.05.
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chemokine receptors, we also assayed the motility of activated WT and CARMA1-/- T
cells treated with pertussis toxin (Ptx). Ptx ADP-ribosylates the α subunit of Gi proteins,
locking them in the inactive state, thus inhibiting signaling through all GPCRs coupled
with Gi proteins, which includes CCR7, the receptor for CCL21 as well as all other
chemokine receptors (Locht, Coutte, & Mielcarek, 2011). Again, we isolated activated
WT and CARMA1-/- T cells, then treated each cell type with 0.5 μg/ml Ptx, then imaged
the T cells on ICAM-1 in the presence of CCL21. We found that the WT T cells and
CARMA1-/- T cells both had a decrease in speed when treated with Ptx as they had in the
absence of CCL21; the T cells adhered and were motile (data not shown), but had a lower
average speed than with normal treatment. The WT T cells migrated at an average speed
of 8.9 μm/min vs. 14.2 μm/min, and the CARMA1-/- T cells migrated at an average speed
of 12.9 μm/min vs. 22.1 μm/min (Figure 9B). Again, even with the decrease in speed
with Ptx treatment, the CARMA1-/- T cells still migrated faster than the WT T cells.
These data indicate that both activated WT and CARMA1-/- T cells are partially
dependent on CCR7 signaling for motility on ICAM-1.

Together, these data indicate that activated WT T cells and CARMA1-/- T cells respond
similarly to CCL21 signaling through CCR7 and that they rely partly on CCR7 signaling
for motility on ICAM-1, and that likely CCR7 is the major chemokine receptor that acts
in both WT T cells and CARMA1-/- T cells to induce motility, as lack of CCL21 and Ptx
treatment showed similar effects. However, even in the absence of CCR7 signaling
activated CARMA1-/- T cell migration is still faster than WT T cell migration, indicating
that the increased speed of the CARMA1-/- T cells is likely not due to chemokine receptor
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signaling, but is due to some other mechanism.

CARMA1 regulates the localization of ERM proteins to the uropod
The data above show that CARMA1 plays a role in expression of migration cell surface
molecules and in T cell motility on ICAM in response to CCL21. T cell motility is
intimately associated with T cell polarization, or the specific localization of proteins to
discrete domains on the migrating T cell. As a T cell migrates, cell surface proteins and
intracellular molecules such as chemokine receptors, actin regulatory proteins, and
cytoskeletal components segregate to the leading edge or uropod to induce T cell
migration. The actin regulatory molecules ERM proteins have been shown to be
important in T cell uropod formation, and thus we asked whether CARMA1 might be
involved in controlling ERM localization.

To do this we used immunofluorescence to analyze the localization of ERM proteins in
naïve WT or CARMA1-/- T cells. We isolated WT and CARMA1-/- T cells from mouse
lymph nodes using nylon wool and placed the T cells on coverslips coated in poly-Llysine, which induces the attachment of T cells. We treated isolated WT and CARMA1-/T cells with CCL21 to induce the migratory phenotype which leads to polarization of
ERM proteins to the T cell uropod. The T cells were fixed and then incubated with
antibodies to either moesin or phospho-ERM (p-ERM), followed by a secondary
fluorescent antibody to detect localization of ERM proteins. We assayed the localization
to the uropod of both moesin and of p-ERM1 in the T cells, since ERMs are
phosphorylated in their active form and phophorylated ERM proteins have been shown to
1 Immunofluorescence data for pERM localization was obtained and analyzed by Ivy Brown.
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localize to the T cell uropod as well (Allenspach et al., 2001).

We found that T cells treated with CCL21 show a typical migratory phenotype, with a
leading edge and the smaller protruding uropod (Figure 10A, B). We counted the number
of T cells which showed the fluorescent signal at the smaller end of the migrating T cell,
which we presumed to be the T cell uropod. We found that a majority of WT T cells with
the migratory phenotype showed moesin localization to the uropod (55%, Figure 10C).
We found that in the CARMA1-/- T cells the localization of moesin to the uropod was
significantly decreased compared to WT (55% WT to 27% CARMA1-/-) (Figure 10C).
When we determined the localization of p-ERM proteins, we found that there was a slight
decrease in p-ERM localization in CARMA1-/- T cells compared to WT cells, however,
the decrease was not statistically significant (Figure 10D). These results indicate that
CARMA1 is important for the localization of the total ERM proteins but affects the
localization of p-ERMs to a lesser degree.
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Figure 10. Localization of moesin and p-ERM in WT and CARMA1-/- T cells. WT and
CARMA1-/- T cells were treated with 300 ng/ml CCL21 and placed on coverslips coated
in poly-L-lysine. The T cells were fixed and labeled with antibodies to detect localization
of moesin and p-ERM. (A&B) Localization of moesin (A) and p-ERM (B) in WT and
CARMA1-/- T cells; the uropod is indicated with an arrow. Moesin and p-ERM are
localized to the uropod in the WT T cells while it is evenly distributed around the
CARMA1-/- T cells. (C&D) Fraction of localization of moesin (C) and p-ERM (D) to the
uropod. Significantly fewer CARMA1-/- T cells had moesin localized to the uropod than
WT T cells. *** indicates p=0.0002, ns = not significant. Differences were considered
statistically significant with p<0.05.
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Summary
These data show for the first time a role for CARMA1 in T cell migration, regulating
multiple aspects of migration. We show that CARMA1 is involved in regulating the
expression of cell surface migration molecules upon activation, specifically regulating
both CD44 and CD62L. In addition CARMA1 is important for localization of ERM
proteins to the uropod. We also show that activated CARMA1-/- T cells move with
increased speed in vitro compared to WT T cells and that activated WT and CARMA1-/T cells both rely partly on signaling from CCL21 through CCR7 for motility. These data
suggest that activated CARMA1-/- T cells may have defective migration to non-lymphoid
tissues, as they do not upregulate CD44 or downregulate CD62L properly. As the WT
and CARMA-/- T cells respond similarly to lack of CCL21 and to inhibition of chemokine
receptor signaling, this is not likely the cause of the increase in activated CARMA1-/- T
cells migration speed. A possible mechanistic basis for the increased speed that we see
in the CARMA1-/- T cells could be the mislocalization of ERM proteins, as this may lead
to improper regulation of the actin cytoskeleton which could affect migration speed.
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2. The role of PKCθ in T cell migration
PKCθ is activated following TCR activation and is involved in signaling pathways
leading to activation of NF-κB, AP-1 and JNK and increased survival, proliferation, and
cytokine production. In these signaling pathways, PKCθ directly phosphorylates
CARMA1, which we have just shown is involved in many aspects of T cell migration.
Because we have shown a novel role for CARMA1 in regulating T cell migration, we
hypothesized that PKCθ would also regulate various aspects of T cell migration.

PKCθ does not regulate expression of migration markers upon T cell activation
Like CARMA1-/- T cells, PKCθ-/- T cells have defective activation and reduced IL-2
production upon activation (Sun et al., 2000). Also as with CARMA1, little is known
about the role of PKCθ in other aspects of T cell function, such as T cell motility. In Part
1, we found that upon T cell activation CARMA1 regulates the expression of CD44 and
CD62L, two cell surface molecules involved in T cell migration that are expressed
differently in naïve and activated T cells. Because PKCθ is known to phosphorylate
CARMA1, we hypothesized that PKCθ would also be involved in regulating the
expression of these migration markers. To investigate the role of PKCθ in the expression
of CD44 and CD62L, we isolated WT and PKCθ-/- T cells on nylon wool and stained
them with CFSE in order to track their proliferation as done in Figure 4. We activated the
T cells as previously described, adding IL-2 to compensate for the decreased IL-2
production of the PKCθ-/- T cells. PKCθ-/- T cells, like CARMA1-/- T cells, were
previously shown to have reduced IL-2 production (Altman et al., 2000). Three days
post activation the cells were analyzed using flow cytometry for proliferation using CFSE
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dilution. We also labeled the cells for CD44 and CD62L expression.

Interestingly, while CARMA1-/- T cells showed defects in CD44 upregulation upon T cell
activation, and we found no defect in the upregulation of CD44 in PKCθ-/- T cells
compared with WT T cells (Figure 11A,B). Similarly, while CARMA1-/- T cells had
defects in CD62L downregulation following T cell activation, we saw that PKCθ-/- T cells
showed similar downregulation of CD62L as WT T cells (Figure 12A,B). While the
PKCθ-/- T cells did proliferate, there were fewer cells recovered at day 3 than in WT T
cells, but there did not appear to be a significant defect in proliferation, at least as
assessed by CFSE dilution (see Figure 12A). These data show that unlike CARMA1,
PKCθ is not involved in regulating the expression of CD44 or CD62L upon T cell
activation.

PKCθ does not affect the motility of activated T cell in vitro
We had previously found that CARMA1-/- T cells showed differences in in vitro motility
compared to WT T cells (Chapter 1 Figure 7). Thus, we also asked whether PKCθ might
also regulate the activity of CARMA1 to control T cell motility. We previously showed
that CARMA1-/- T cells have increased speed in the presence of CCL21 on ICAM-1 in
vitro, so this led us to investigate whether PKCθ-/- T cells show a similar change in
motility. To do this we used the in vitro motility assay as described in Figure 6 and 7.
We activated WT and PKCθ-/- T cells as previously described and 7-9 days post activation
isolated the live cells on a Ficoll gradient. Again we imaged the WT and PKCθ-/- T cells
on ICAM-1 coated dishes in the presence of CCL21. We analyzed individual cells in the
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Figure 11. PKCθ-/- T cells upregulate CD44 like WT T cells. PKCθ-/- T cells upregulate
CD44 like WT T cells. Naive T cells isolated from lymph nodes were stained with 5μM
CFSE and activated with α-CD3 and α-CD28 for 3 days before analysis. Activated T
cells were stained with fluorescent α-CD44 prior to analysis with flow cytometry. (A)
Decreased CFSE intensity indicates cells that have proliferated. (B) Histogram
comparing CD44 intensity. No difference was seen in CD44 intensity between WT and
PKCθ-/- T cells.
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Figure 12. PKCθ-/- T cells downregulate CD62L like WT T cells. Naive T cells isolated
from lymph nodes were stained with 5μM CFSE and activated with α-CD3 and α-CD28
for 3 days before analysis. Activated T cells were stained with fluorescent α-CD62L
prior to analysis with flow cytometry. (A) Decreased CFSE intensity indicates cells that
have proliferated. The areas indicated with the red square show cells that have
proliferated and have downregulated CD62L. WT and PKCθ-/- T cells had similar
percentages of T cells that had proliferated and downregulated CD62L. (B) Histogram
comparing CD44 intensity.
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videos, tracking them for 5-7 minutes of continuous unobstructed adhesion. We found
that unlike the CARMA1-/- T cells, there was no difference between activated WT and
PKCθ-/- T cells in average speed, maximum speed, or chemotactic index (Figure 13). We
also compared the motility of naïve WT and PKCθ-/- T cells, and we again saw no
difference between the in vitro motility of WT and PKCθ-/- T cells (Figure 14). These
data show that unlike CARMA1, PKCθ does not affect the motility of activated T cells on
ICAM-1 in vitro.

PKCθ does not affect T cell dependence on CCR7 signaling for activated T cell
motility in vitro
Naïve T cells are dependent on CCL21 signaling through CCR7 for motility in vitro on
ICAM-1, while activated T cells are less dependent. Our previous results have shown
that activated WT T cells have a partial dependence on CCL21/CCR7 signaling for
motility on ICAM-1, and while CARMA1-/- T cells also have a partial dependence on
CCR7 signaling for T cell motility, they also likely utilize other chemokine receptors to
affect motility. We have also shown that PKCθ does not play a role in the motility of
naïve or activated T cells on ICAM-1 in vitro. This lead us to investigate the role of
PKCθ in CCR7 mediated migration. We activated WT and PKCθ-/- T cells as previously
described and 7 to 9 days post activation isolated the live cells using Ficoll. To test the
role of CCL21 we placed activated WT and PKCθ-/- T cells on ICAM-1 coated dishes in
the absence of CCL21. We found that the PKCθ-/- T cells responded similarly to WT T
cells, and the speed of the WT and PKCθ-/- T cells was similar in the absence of CCL21
(Figure 15A). The average speed of WT T cells in the absence of CCL21 was
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Figure 13. Activated PKCθ-/- T cells migrate on ICAM-1 with similar speed and
chemotactic index as WT T cells. WT and PKCθ-/- T cells were activated with α-CD3
and α-CD28 7-9 days prior to the in vitro migration assay. T cells were suspended in
media with 300ng/ml CCL21 and placed on dishes coated with ICAM-1. T cells were
imaged in a 37ºC 5% CO2 humidified chamber starting 15 minutes after being placed in
the chamber, taking time-lapse images in 2 second increments for up to 10 minutes.
Videos of activated WT and PKCθ-/- T cells were analyzed and individual cells tracked
for 5-7 minute intervals. Average speed (A), Maximum speed (B), and Chemotactic
index (C) were assessed; no significant difference was seen in any of the parameters
assessed.
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Figure 14. Naïve PKCθ-/- T cells migrate on ICAM-1 with similar speed and chemotactic
index as WT T cells. Naïve WT and PKCθ-/- T cells were isolated and suspended in
media with 300ng/ml CCL21 and placed on dishes coated with ICAM-1. T cells were
imaged in a 37ºC 5% CO2 humidified chamber starting 1 hour after being placed in the
chamber, taking time-lapse images in 2 second increments for up to 10 minutes. Videos
of activated WT and PKCθ-/- T cells were analyzed and individual cells tracked for 5-7
minute intervals. Average speed (A), maximum speed (B), and chemotactic index (C)
were determined; no significant difference was seen in the parameters assessed.
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Figure 15. Activated WT and PKCθ-/- T cells are partially dependent on CCL21 and
CCR7 signaling for migration on ICAM-1. WT and PKCθ-/- T cells were activated with
α-CD3 and α-CD28 7-9 days prior to the in vitro migration assay. T cells were imaged on
dishes coated with ICAM-1 in a 37ºC 5% CO2 humidified chamber starting 15 minutes
after being placed in the chamber, taking time-lapse images in 2 second increments for up
to 10 minutes. Videos of activated WT and PKCθ-/- T cells were analyzed and individual
cells tracked for 5-7 minute intervals. (A) WT and PKCθ-/- T cells were imaged either in
media with 300ng/ml CCL21 (+CCL21) or in media with no CCL21 (-CCL21). Both
WT and PKCθ-/- T cells had slower average speeds in the absence of CCL21. (B) WT
and PKCθ-/- T cells were either treated with 0.5μg/ml pertussis toxin (+Ptx) or imaged
without treatment (Control). Both conditions were imaged in media with 300ng/ml
CCL21. WT and PKCθ-/- T cells both moved with a slower average speed following Ptx
treatment than the untreated T cells. *: p=0.0182, **: p=0.0014, ***: p<0.0001.
Differences were considered statistically significant with p<0.05.
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9.9μm/min, down from 14.2μm/min when CCL21 was present, and the average speed of
PKCθ-/- T cells in the absence of CCL21 was 10.5μm/min compared to 15.1μm/min with
CCL21 (Figure 15A). These results indicate that activated WT and PKCθ-/- T cells are
both dependent on CCL21 for motility to a similar degree.

To test that these effects are through chemokine receptors, we treated the WT and PKCθ-/T cells with pertussis toxin (Ptx) to inhibit all GPCRs, including CCR7, and imaged the
treated cells in the presence of CCL21. We saw a similar decrease in average speed in the
Ptx treated WT T cells as in the untreated cells without CCL21, the Ptx treated WT T
cells migrated at 8.9μm/min, down from 14.2μm/min in the untreated WT T cells (Figure
15B), suggesting that most of the motility we observed was due to CCR7. We saw that
the PKCθ-/- T cells responded similarly to Ptx treatment as the WT T cells; we saw a
decrease in average speed in the Ptx treated cells to 12.5μm/min compared to
15.1μm/min in the untreated T cells (Figure 15B). However, unlike in the T cells without
CCL21, we found that the speed of the PKCθ-/- T cells did not decrease as much as the
WT T cells following Ptx treatment, and that they moved significantly faster, and the Ptx
treated PKCθ-/- T cells moved slightly faster than the PKCθ-/- T cells with no CCL21,
although the difference was not significant (Figure 15B). These data show that PKCθ-/- T
cells respond to CCL21 signaling through CCR7 similarly to WT T cells.

Together these data show that activated WT and PKCθ-/- T cells are both partially
dependent on CCL21 signaling through CCR7 for motility, and CCR7 is likely the major
chemokine receptor inducing motility in both WT and PKCθ-/- T cells because they
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respond similarly to both lack of CCL21 and Ptx treatment. The PKCθ-/- T cells treated
with Ptx moved slightly faster than those with no CCL21, but this may be due to
inefficient treatment with Ptx as Ptx treatment should reduce the speed of the T cells at
least as much as the lack of CCL21 does due to blocking of CCR7.

PKCθ regulates the localization of ERM proteins to the uropod
We have shown in the data above that PKCθ does not play a role in regulating CD44 and
CD62L expression as well as in vitro motility. However, the localization of proteins in a
polarized T cell is very important for motility and PKCθ is already known to interact with
proteins that localize to the uropod. Specifically, PKCθ has been shown to phosphorylate
moesin directly (Pietromonaco, Simons, Altman, & Elias, 1998). As moesin is the most
abundant ERM protein found in T cells, and we have already shown that CARMA1 plays
a role in localizing ERM proteins to the uropod, we investigated whether PKCθ also
plays a role in the localization of ERM proteins.

To do this we isolated T cells from WT and PKCθ-/- mice on nylon wool and used
immunofluorescence as previously described to analyze the localization of moesin and pERM in the cells after CCL21 treatment. We again saw the typical migratory phenotype
upon CCL21 treatment, with a leading edge and the uropod (Figure 16A,B). We found
that like CARMA1-/- T cells, PKCθ-/- T cells showed less polarization of moesin to the
uropod than WT T cells; only 31% localized compared to 55% (Figure 16C).
Additionally, we found that in the PKCθ-/- T cells there was also less polarization of pERM to the uropod with only 40% polarized compared to 70% in WT T cells (Figure
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Figure 16. Localization of moesin and p-ERM in WT and PKCθ-/- T cells. WT and
PKCθ-/- T cells were treated with 300 ng/ml CCL21 and placed on coverslips coated in
poly-L-lysine and the T cells were fixed and labeled with antibodies to detect localization
of moesin and p-ERM. . (A) The localization of moesin in WT and PKCθ-/- T cells; the
uropod is indicated with an arrow. Moesin is localized to the uropod in the WT T cell
while it is evenly distributed around the PKCθ-/- T cell. (B) The localization of p-ERM in
WT and PKCθ-/- T cells; the uropod is indicated with arrow. The WT T cell shows
localization of p-ERM to the uropod, while the PKCθ-/- T cell shows the p-ERM
distributed more toward the leading edge. (C&D) Quantification of the localization of
moesin (C) and p-ERM (D) to the uropod. Significantly fewer PKCθ-/- T cells had
moesin and p-ERM localized to the uropod than WT T cells. *** indicates p=0.0002, *
indicates p=0.0233. Differences were considered statistically significant with p<0.05.
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16D). These data show that PKCθ does play a role in regulating the localization of ERM
proteins to the uropod, and that it affects the localization of both phosphorylated and nonphosphorylated forms of these proteins.

Summary
In this chapter our data show that PKCθ does not play a role in regulating many aspects
of T cell migration including expression of the migration markers CD44 and CD62L, T
cell motility on ICAM-1, and CCR7 induced motility. However, PKCθ does play a role
in the localization of proteins that are involved in T cell migration, the ERM proteins, in
both an active and inactive form. The effect of PKCθ on T cell migration contrasts with
that of CARMA1, showing that while these two molecules coordinately regulate TCR
induced NF-κB activation, the two diverge in regulation of T cell migration downstream
of chemokine receptors. These data also indicate for the first time that the role of
CARMA1 in regulating T cell migration is likely to be in a PKCθ-independent manner.
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3. The role of PKCθ in Francisella tularensis infection
The role of PKCθ in infection
The requirement for PKCθ in immune responses is not entirely understood. As discussed
in the introduction, it has been shown to be important for both Th17 and Th2 responses,
and sometimes for Th1 and cytotoxic T cell responses. An early study showed that NFκB was involved in the production of cytokines in the EAE model of multiple sclerosis,
including cytokines important for Th1 (IL-2 and IFNγ) and Th2 (IL-4 and IL-10)
responses (Hilliard, Samoilova, Liu, Rostami, & Chen, 1999). Since PKCθ is involved in
NF-κB activation, defective NF-κB downstream of PKCθ-deficiency may explain why
PKCθ deficient mice also show decreased production of these specific cytokines.

One type of response that PKCθ has been shown to be important for is Th1/Th17
responses. PKCθ deficient mice were protected in models of chronic intestinal
inflammation and experimental autoimmune enchephalomyelitis (EAE), both of which
are characterized by Th1 and Th17 induced inflammation, with reduced expression of
IFNγ and IL-17 (Anderson et al., 2006; Tan et al., 2006). Another study showed that
PKCθ was required for development of experimental autoimmune myocarditis (EAM),
which also requires a Th17 response, and that there was reduced differentiation of Th17
cells in the absence of PKCθ (Marsland et al., 2007). These data indicate that PKCθ
plays a role in the differentiation of Th17 cells and in the production of Th1 and Th17
cytokines.

PKCθ has also been shown to be required for a Th2 response. A study looking at the
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immune response to infection by the helminth Nippostrogylus brasiliensis and airway
hyperresponsiveness to allergen, both which require a Th2 response, found that PKCθ-/mice were unable to generate a Th2 response to either, but that addition of exogenous IL2 to PKCθ-/- T cells was able to induce Th2 development (Marsland et al., 2004). PKCθ
was also shown to be required for an effective response against Toxoplasma gondii, a
parasite infection that requires a Th2 response to control (Nishanth et al., 2010). These
data show that PKCθ is required for Th2 responses, and this requirement is likely partly
due to the role of PKCθ in production of IL-2, which is an important cytokine for Th2
development.

Another role for PKCθ in immune responses in some cases is in regulation of adhesion
molecule expression. PKCθ-deficiency was shown to protect mice from Plasmodium
berghei ANKA (PbA) induced cerebral malaria in two studies. A 2010 study showed that
there was reduced Th1 cytokine (IFNγ and TNFα) production and reduced upregulation
of LFA-1 in response to PbA infection in PKCθ-/- mice (Ohayon et al., 2010). A 2011
study showed recruitment of activated T cells to the brain was reduced and the
upregulation of ICAM-1 was reduced in PKCθ-deficient mice (Fauconnier et al., 2011).
LFA-1 was also not upregulated in response to MOG in one of the studies using EAE as a
model (Tan et al., 2006). These data indicate that PKCθ may not only be involved in T
cell differentiation in response to infection, but also in the regulation of adhesion
molecule expression to regulate T cell response to infection.

On the other hand, PKCθ does not seem to be required for some Th1 and cytotoxic T cell
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responses. It was found that the PKCθ-/- mice were able to generate an effective immune
response to Leishmania major, which requires a Th1 response (Marsland et al., 2004). In
another study, PKCθ was not required for clearance of viral infection caused by murine
gammaherpesvirus 68 (MHV-68), which requires a T cell response, and T cell expansion
and migration to the site of infection, particularly CD8+ T cells, was the same in both
PKCθ-/- and WT mice (Giannoni et al., 2005). A 2005 study demonstrated that T cells
may get signals from other sources in the absence of PKCθ. The authors showed that
PKCθ was not necessary for antiviral CD8+ T cell responses to multiple viruses,
including influenza and vaccinia virus and that this was because the T cells could get
activation signals from TLR activated dendritic cells in the absence of PKCθ (Marsland
et al., 2005). These data show that for some T cell responses PKCθ is not required, and
this may be due to having other signals that can fulfill the role of PKCθ in its absence.

In summary, PKCθ was shown to be involved in Th17 and Th2 differentiation, as well as
in the production of multiple Th1, Th2, and Th17 cytokines. PKCθ is also involved in
the regulation of expression of some adhesion molecules, particularly LFA-1, and so
PKCθ-deficiency affects the migration of T cells to infection sites in some cases.
However, PKCθ is not required for some immune responses, including some Th1 and
cytotoxic T cell responses, and in some cases this is due to T cells receiving activation
signals from other sources when PKCθ is absent.

The role of T cells in F. tularensis infection
The role of PKCθ in Francisella tularensis infection has not been studied previously. We
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know that T cells are very important in F. tularensis infection because mice lacking T
cells are unable to clear the infection and eventually succumb (K L Elkins et al., 1996).
There are 4 T cell populations that can play a role in clearing an F. tularensis infection:
CD4+ T cells, CD8+ T cells, CD4− CD8− NK1.1− TCRαβ+ Thy1.2+ or “DN” T cells, and
γδ+ T cells. Either CD4+ or CD8+ T cells are individually able to clear infection (Yee et
al., 1996), while DN T cells alone are able to control an F. tularensis infection for months
with a chronic infection but are unable to clear it (Cowley et al., 2005). A γδ+ T cell
population has been shown to increase in humans when exposed to F. tularensis antigen
(Poquet et al., 1998). All four of these T cell populations, CD4+, CD8+, DN, and γδ+,
produce the cytokines IFNγ and TNFα which are important for helping to control the
growth of F. tularensis in macrophages (Cowley & Elkins, 2011).

While the T cell populations involved in immunity to F. tularensis have been investigated,
little is known about specific molecules that might regulate immunity to tularensis. So
we investigated whether PKCθ might play a role. Because the T cell response is critical
for clearing F. tularensis infection, and because PKCθ is critical for T cell proliferation
and survival, we hypothesized that PKCθ would be important in the immune response to
infection with F. tularensis.

PKCθ deficiency protects against lethal Francisella tularensis infection
We wanted to investigate whether PKCθ was important for immunity against F. tularensis
infection. To do this, we assessed whether there was a difference in survival between WT
and PKCθ-/- mice following infection with F. tularensis. For our studies, we used the live

55

vaccine strain (LVS), which is very infectious and deadly in mice but not in humans. We
infected age and sex matched WT and PKCθ-/- mice intranasally (IN) with 1x105 cfu of
LVS and determined survival of infected mice. Surprisingly, we found that the PKCθ-/mice had better survivability than the WT mice. The WT mice started dying around day
7 or 8 post infection and all died within less than two weeks (Figure 17A). The PKCθ-/mice had much better survival, only 66% died and the surviving mice living for more
than 40 days (Figure 17A). The trend remained when we infected WT and PKCθ-/- mice
with a 10-fold lower dose of LVS (1x104 cfu); 60% of the WT mice died while only 15%
of the PKCθ-/- mice died (Figure 17B). To control for possible differences between the
inbred WT (C57Bl/6) and homozygous C57Bl/6.PKCθ-/- strains, we back bred
C57Bl/6.PKCθ-/- mice to the WT C57Bl/6 and generated PKCθ+/+ (WT), PKCθ+/- (het),
and PKCθ-/- mice. We infected littermates that were sex and age matched WT (PKCθ+/+),
PKCθ+/-, and PKCθ-/- mice with LVS, and found that while the PKCθ-/- still showed
increased survival in two separate infections with 1x105 cfu (0% and 45% died) and the
WT still nearly all died (100% and 86% died). The survival of the heterozygous PKCθ+/mice was less than the PKCθ-/- mice and greater than WT in all experiments done (Figure
17C,D). This shows that the partial loss of PKCθ in the heterozygous PKCθ+/- mice also
offers some protection. These results show that PKCθ-deficiency confers protection
against F. tularensis.

PKCθ regulates the T cell populations present in infected tissue following F.
tularensis infection
To determine why the PKCθ-/- mice survived longer than the WT mice, we infected WT
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Figure 17. PKCθ-deficiency confers protection against F. tularensis. (A,B) WT and
PKCθ-/- mice were infected IN with 1x105 cfu or 1x104 cfu of LVS and survival was
tracked for up to 40 days. PKCθ-/- mice had better survival following inoculation with
1x105 cfu and a higher percentage of PKCθ-/- mice survived inoculation with 1x104 cfu.
(C,D) WT, PKCθ+/-, and PKCθ-/- mice from a WT x PKCθ-/- backbreeding were infected
with 1x105 cfu of LVS and survival was tracked for 3 weeks. WT and PKCθ-/- mice
showed the same trend as before and the heterozygous PKCθ+/- mice were partially
protected from LVS infection.
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mice and PKCθ-/- mice IN with 1x105 cfu of LVS, and then harvested organs from
infected mice 7 days post infection to determine the effect of PKCθ on immune cell
infiltration during infection. To ask whether increased survival in PKCθ-/- mice was a
result of enhanced immune cell infiltration during infection, we determined the extent of
immune cell infiltration into organs of infected mice at day 7. Day 7 is just prior to the
time the WT mice usually started to die, and the day 7 time point allowed us to quantify
immune cells in infected organs just before the infected mice succumb to infection.
Because the F. tularensis bacteria were introduced IN, the organ expected to be the main
site of infection was the lung. Thus we harvested the lungs as well as the mediastinal
lymph nodes, which are the draining lymph nodes from the lung (designated DLN). We
also harvested the liver and spleen, as others have reported that there is infection in the
liver and spleen as well following pulmonary infection (J Wayne Conlan, Chen, Shen,
Webb, & KuoLee, 2003). As a control, we determined immune cell composition in the
inguinal lymph nodes as non-draining lymph nodes (NDLN) that should not be infected.

We harvested DLNs, NDLNs, spleen, liver, and lung from infected WT and PKCθ-/- mice
and analyzed the cells from each organ using flow cytometry. We assessed total T cells
by gating on CD3+, then gated on CD4 and CD8 to assess CD4+, CD8+, and CD4- CD8T cell sub-populations. We were unable to get results from the DLN due to the fact that
the DLN in the WT mice were very small and so we were either unable to find them, or
unable to get many cells from them (data not shown). This is likely due to the mice
having a very severe infection, and the infected tissue, including the lungs and DLN,
becoming necrotic. We found that in the lungs, there was not a significant difference in
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the total number of T cells between WT and PKCθ-/- (data not shown), but of the total T
cells in the lungs, a significantly smaller percentage were CD4+ T cells in lungs from the
PKCθ-/- mice (51%) than in lungs from the WT mice (59%) (Figure 18A). Interestingly,
there was no significant difference in the percentage of T cells that were CD8+ in the
lungs of infected PKCθ-/- mice compared to the lungs of infected WT mice (25% in WT
versus 22% in PKCθ-/-) (Figure 18B), but there was a significantly higher percentage of
CD4-CD8- T cells in the lungs of PKCθ-/- mice (25% of the T cells from PKCθ-/- were
CD4- CD8-, versus 15% in the lungs of WT mice) (Figure 18C).

The results in the liver were somewhat different than the lungs. Unlike in the lungs, we
saw about 4-fold fewer T cells in the livers of infected PKCθ-/- mice compared to the
livers of infected WT mice, (6x105 T cells in PKCθ-/- compared to 2x106 T cells in WT).
However, like in the lungs, there was a smaller percentage of CD4+ T cells in the livers of
infected PKCθ-/- mice compared to the livers of infected WT mice (47% PKCθ-/compared to 62% WT) (Figure 19A). In contrast, unlike the lung, there were more CD8+
T cells in the livers of infected PKCθ-/- mice than in the livers of infected WT mice (28%
PKCθ-/- compared to 22% WT) (Figure 19B). Again, there was a higher percentage of
CD4- CD8- T cells in the livers of infected PKCθ-/- mice (24%) compared to the livers of
infected WT mice (15%) (Figure 19C).

In the spleen we saw similar results to what we saw in the lung. There was no significant
difference in total number of T cells (data not shown) or percentage of T cells that are
CD8+ (35% CD8+ T cells in the spleens of infected PKCθ-/- mice compared to 31% CD8+
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Figure 18. PKCθ-/- mice infected with LVS have different T cell populations in the lungs
than infected WT mice. WT and PKCθ-/- mice were infected with 1x105 cfu of LVS and
then the lungs were harvested from the mice 7 days post infection and the T cell
composition in the lungs was determined with flow cytometry. The lungs of infected
PKCθ-/- mice had a smaller percentage of CD4+ T cells (A) and a larger percentage of
CD4-CD8- T cells (B) than the lungs of infected WT mice. There was no significant
difference in CD8+ T cells. *: p=0.0337, **: p=0.0045, ns: not significant. Differences
were considered statistically significant with p<0.05.
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Figure 19. PKCθ-/- mice infected with LVS have different T cell populations in the liver
than infected WT mice. WT and PKCθ-/- mice were infected with 1x105 cfu of LVS and
then the livers were harvested from the mice 7 days post infection and the T cell
composition in the lungs was determined with flow cytometry. The livers of infected
PKCθ-/- mice had a smaller percentage of CD4+ T cells (A), and greater percentages of
CD8+ T cells (B) and CD4-CD8- T cells (C). *:p=0.0420, **:p=0.0063, ***:p=0.0031.
Differences were considered statistically significant with p<0.05.
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Figure 20. PKCθ-/- mice infected with LVS have different T cell populations in the spleen
than infected WT mice. WT and PKCθ-/- mice were infected with 1x105 cfu of LVS and
then the spleens were harvested from the mice 7 days post infection and the T cell
composition in the spleens was determined with flow cytometry. The spleens of infected
PKCθ-/- mice had a smaller percentage of CD4+ T cells (A), no significant difference in
percentage of CD8+ T cells (B), and a higher percentage of CD4-CD8- T cells (C) than the
spleens of infected WT mice. *: p=0.0095, **: p=0.0017, ns: not significant. Differences
were considered statistically significant with p<0.05.
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T cells in the spleens of infected WT mice) (Figure 20B). But there was a smaller
percentage of CD4+ T cells in the spleens of infected PKCθ-/- mice compared to the
spleens of infected WT mice (52% PKCθ-/- versus 62% WT) (Figure 20A). There was a
higher percentage of CD4- CD8- T cells in the spleens of infected PKCθ-/- mice compared
to spleens of the infected WT mice (12.5% PKCθ-/- versus 7.5% WT) (Figure 20C). In
contrast to the lung, liver, and spleen, we found no difference in total T cells or
percentages of T cell subpopulations in the NDLNs of infected PKCθ-/- mice compared to
the NDLNs of infected WT mice (37% CD4+ T cells PKCθ-/- versus 38% CD4+ T cells
WT , 55% CD8+ T cells PKCθ-/- versus 56% CD8+ T cells WT, 8% CD4-CD8- T cells
PKCθ-/- versus 5% CD4- CD8- T cells WT).

These results show that the T cell populations in the lungs, liver, and spleen upon
infection are different in PKCθ-/- mice infected with F. tularensis compared to infected
WT mice. We saw that a decreased T cells were CD4+ T cells and an increased
percentage of T cells were CD4-CD8- T cells in the lungs, livers and spleens of the
infected PKCθ-/- mice compared to the WT mice. These data suggest that differential T
cell populations may contribute to the protection seen in PKCθ-/- mice.

Activated PKCθ-/- T cells have an increased population of CD4- CD8- T cells
The increased population of CD4-CD8- T cells present in the lungs, liver, and spleen of
the PKCθ-/- mice suggests that the presence of CD4-CD8- T cells may contribute to
protection against F. tularensis. There are at least two possible mechanisms by which
PKCθ may lead to the increased number of CD4-CD8- T cells. First, CD4-CD8- T cells
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may come from increased migration to the sites of infection in response to LVS. Second,
the PKCθ-/- mice may generate more CD4-CD8- T cells, resulting in increased numbers
we see in infected tissues. To ask if PKCθ affects generation of CD4-CD8- T cells, we
purified WT and PKCθ-/- T cells from uninfected mice and activated the T cells in vitro
using anti-CD3 and anti-CD28 as described in Fig. 1. At 7 days after activation we
looked at the expression of CD4 and CD8 via flow cytometry. We found that nearly all of
the activated WT T cells were either CD4+ or CD8+ and very few were either double
positive or double negative T cells (60% CD4+, 35% CD8+, 3% CD4-CD8-, and 2%
CD4+CD8+) (Figure 21A). In contrast, in activated PKCθ-/- T cells while there were still
large populations of single positive CD4+ and CD8+ T cells (22% CD4+, 56% CD8+),
there was also a significant population of CD4-CD8- T cells present that was not found in
the activated WT T cells (19% CD4-CD8-) (Figure 21A).

One possibility for the increased numbers of DN T cells could be due to a T cell
development effect, with PKCθ-/- mice having more DN T cells in the naïve cell pool
before activation. To test for this possibility, we also analyzed naïve WT and PKCθ-/- T
cell repertoires for CD4 and CD8 via flow cytometry, and found that there was no
difference in the percentage of CD4+, CD8+ and CD4-CD8- T cell populations between
WT and PKCθ-/- mice (Figure 21B). These data indicate that upon activation PKCθ-/- T
cells are able to generate a greater population of CD4- CD8- T cells, suggesting that this
may be part of the reason for increased numbers of this population of T cells in LVS
infected organs.
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Figure 21. Activated PKCθ-/- T cells have an increased population of CD4- CD8- T cells.
(A) Naïve T cells were isolated from WT and PKCθ-/- mice and activated with α-CD3 and
α-CD28 for 7 days before analysis. T cells were stained with fluorescent α-CD4 and αCD8 prior to analysis with flow cytometry. Population in the red square indicates the
CD4- CD8- T cells. CD4- CD8- T cells made up 19% of the PKCθ-/- T cells, while the
CD4- CD8- T cells made up less than 3% of the WT T cells. (B) Naïve T cells were
isolated from WT and PKCθ-/- mice and stained with fluorescent α-CD4 and α-CD8 prior
to analysis with flow cytometry. No difference was seen between the T cell populations
of PKCθ-/- T cells compared to WT T cells.
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Summary
In summary, we found that PKCθ-/- mice are protected against infection with F. tularensis,
and that infected PKCθ-/- mice have increased populations of CD4-CD8- T cells and
decreased populations of CD4+ T cells in the lungs, liver, and spleen compared to
infected WT mice. We also found that upon activation, PKCθ-/- T cells have an increased
population of CD4-CD8- T cells, indicating a potential source for the increased numbers
of CD4-CD8- T cells seen in the infected organs.
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DISCUSSION
1. The roles of PKCθ and CARMA1 in T cell migration
T cells are an important part of the adaptive immune system, and perform multiple
functions, including directly killing infected cells and helping to activate other immune
effectors. In order to properly function, T cells must be able to migrate throughout the
body, first naïve T cells must scan the lymph nodes for their cognate antigen, then once
activated, T cells must migrate to the site of infection where they can perform their
effector function. T cells use multiple cell surface molecules to migrate, including
selectins, chemokine receptors, and integrins. These molecules and their roles in T cell
migration have been well studied, but the intracellular signaling involved in regulating T
cell migration is not well understood. In this study we investigated two proteins that are
well established in signaling downstream of TCR activation, CARMA1 and PKCθ, to
determine their roles in T cell migration.

Downstream of TCR signaling, PKCθ plays a role in multiple signaling pathways,
including activation of AP-1 and NFAT, but PKCθ's role in NF-κB activation appears to
be the most important (Altman et al., 2000). Both CARMA1 and PKCθ are known to be
part of the NF-κB signaling pathway, with PKCθ directly phosphorylating CARMA1, and
eventually leading to NF-κB activation (Blonska & Lin, 2009). CARMA1 is
constitutively at the plasma membrane, associated with lipid rafts, and upon TCR
activation associates with the TCR in the immune synapse (IS) (Gaide et al., 2002).
PKCθ is normally in the cytosol, but is recruited to the IS as well upon TCR activation
(Villalba, 2004). CARMA1 is phosphorylated at several different sites, but the
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phosphorylation in the linker region at S552 and S635 by PKCθ is the most important
and this phosphorylation is required to recruit other signaling components (R. Matsumoto
et al., 2005; Thome, Charton, Pelzer, & Hailfinger, 2010). Phosphorylated CARMA1 can
then bind to BCL10 and MALT1, forming the CBM complex. The CBM complex helps
with the degradation through ubiquitination of NEMO (IKKγ), the regulatory subunit of
the IκB kinase (IKK) complex (Smith-Garvin, Koretzky, & Jordan, 2009). PKCθ can
also interact directly with the IKK complex and may be involved in bringing the IKK to
the CBM (M S Hayden, West, & Ghosh, 2006) The IKK complex can then
phosphorylate IκB, leading to its degradation and activating NF-κB (M S Hayden et al.,
2006). NF-κB then translocates into the nucleus and acts as a transcription factor,
regulating the transcription of genes involved in apoptosis, proliferation, IL-2 production,
and T helper cell differentiation (Matthew S Hayden & Ghosh, 2011).

Because they are both involved in this crucial pathway, the effects of CARMA1
deficiency and PKCθ deficiency are similar when looking at T cell activation, including
reduced proliferation and IL-2 production. CARMA1 deficient T cells were unable to
activate IKK following CD3/CD28 costimulation, and had deficient IL-2 production
(Wang et al., 2002). Another study also shows poor IL-2 production in CARMA1
deficient T cells, as well as impaired proliferation as a result of the lack of IL-2 (Egawa,
Albrecht, Favier, & Sunshine, 2003). PKCθ deficient T cells also have a defect in NFκB activation and decreased IL-2 production and proliferation (Sun et al., 2000).

While the roles for PKCθ and CARMA1 in response to T cell receptor activation are well
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studied, their roles in other T cell functions are unknown. For example, not much is
known about the signaling pathways involved in T cell migration. Several studies offer
possible connections of PKCθ to regulation of T cell migration. One study showed that a
motile phenotype was induced in T cells when PKCs were inhibited (Southern et al.,
1995). Another study showed that PKCθ is involved in activation of Rap1, which leads
to increased adhesion of LFA-1 on T cells downstream of TCR activation (Letschka et al.,
2008). PKCθ was also found to phosphorylate CD43, which associates with ERM
proteins in polarized T cells and promotes migration (Cannon et al., 2011). Because
CARMA1 is directly downstream of PKCθ it seemed a likely candidate for a role in
regulating T cell migration as well. This led us to investigate the roles of PKCθ and
CARMA1 in various aspects of T cell migration.

Chemokine receptor signaling is important for T cell migration, activating pathways that
lead to uropod and leading edge formation, polarization of the cell, and integrin
activation (Kinashi, 2005). Much less is known about the signaling downstream of
different chemokine receptors than is known about the signaling pathways upon TCR
activation, but several signaling components have been shown to be common to both
TCR and chemokine receptor activation. Rap1 and 2 are activated downstream of both
the TCR and chemokine receptors, and lead to integrin activation (Abram & Lowell,
2009). Signaling through the chemokine receptor CXCR4 was shown to lead to
activation of ERK1 and 2, PI3K, and NF-κB (Ganju et al., 1998). PI3K is activated
downstream of both the TCR and chemokine receptors, regulating migration and T cell
activation (Ward, 2004). The PI3K subunit p110γ was shown to be important for
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chemotactic responses to CCL19 and CCL21 (which bind to CCR7), and CXCL12
(which binds CXCR4) (Reif et al., 2004). Yet another shared pathway between TCR
signaling and chemokine receptor signaling is via activation of LFA-1. Both chemokine
receptors and TCR signaling contribute to the redistribution of the LFA-1 to allow for
rapid adhesion when there is not a high density of ICAM for the LFA-1 to bind to
(Constantin et al., 2000).

Pathways traditionally considered exclusively downstream of TCR or chemokine
receptors have recently been shown to cooperate as well. Migration of T cells induced by
CXCL12 (ligand to CXCR4) was reduced in mice lacking functional ZAP-70, which is
also involved in signaling downstream of the TCR (Ottoson, Pribila, Chan, & Shimizu,
2001). Later it was shown that CXCR4 actually associates with the TCR to activate
ZAP-70 (Kumar et al., 2006). Recently a study demonstrated that short-term TCR
activation increased the migration of T cells toward CCL19 and CCL21, indicating that
the signaling through the TCR and CCR7 can cooperate to control the migration of the T
cells (Schaeuble, Hauser, Singer, Groettrup, & Legler, 2011).

We now identify a novel role for CARMA1 and PKCθ in regulating T cell migration.
However we found that CARMA1 and PKCθ do not regulate the same aspects of T cell
migration. We have shown that CARMA1 plays a role in regulating many aspects of T
cell migration, including cell surface expression of motility markers, speed of migrating
T cells in vitro, signaling through CCR7 to induce motility, and ERM protein localization
to the uropod. On the other hand, we showed that PKCθ does not play a role in
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regulating the expression of motility markers, migrating T cell speed, or CCR7 signaling
in T cell motility, but does regulate the localization of ERM proteins. These results
suggest that many of the ways that CARMA1 regulates T cell migration are likely to
occur independently of PKCθ. Our findings show that while both TCR induced NF-κB
signaling and T cell migration involve PKCθ and CARMA1, the mechanism by which
PKCθ and CARMA1 regulate these two pathways is fundamentally different.

Our data shows that CARMA1 can regulate CD62L downregulation upon T cell
activation. CD62L expression is downregulated by first proteolytic cleavage and then by
gene transcription downregulation (Chao, Jensen, & Dailey, 1997). However, the
signaling pathway that leads to this downregulation is not fully understood. The
transcription factor KLF2 is known to directly activate the promoter of CD62L (Bai, Hu,
Yeung, & Chen, 2007; Sebzda, Zou, Lee, Wang, & Kahn, 2008). PI3K has been shown
to be involved in the shedding of CD62L from the surface of the T cells upon TCR
activation (Sinclair et al., 2008). Sinclair et al. also showed that PI3K is also involved in
suppressing transcription of the CD62L gene, through mTOR. This inhibition is through
suppression of KLF2 (Finlay & Cantrell, 2010). Our results show that CARMA1 is
involved in this pathway. CARMA1 interacts with Akt downstream of TCR signaling to
activate NF-κB (Thome et al., 2010). Since Akt is part of the signaling pathway to
activate mTOR CARMA1 may regulate CD62L expression via Akt and KLF2. We
found that PKCθ deficiency does not result in any defects in CD62L downregulation,
showing that PKCθ phosphorylation of CARMA1 is likely not to play a role in
CARMA1-dependent CD62L regulation.
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We also find that CARMA1 is involved in CD44 upregulation as well as CD62L
downregulation. CD44 upregulation is induced by TCR activation and the increased
level of CD44 is sustained on effector T cells and memory T cells (Baaten, Tinoco, Chen,
& Bradley, 2012). NF-κB is a known transcription factor for CD44 (Hinz et al., 2002),
and since we know CARMA1 deficient T cells have poor NF-κB activation, that is the
likely explanation for the inability of CARMA1-/- T cells to upregulate CD44. However,
PKCθ deficient T cells also have impaired NF-κB signaling, but we did not see a
deficiency in the upregulation of CD44 in the PKCθ-/- T cells. This suggests that there
may be another signaling pathway in which CARMA1 but not PKCθ is involved that also
regulates CD44 expression.

CD44 is involved in trafficking to inflamed sites, and CD62L is responsible for homing
of T cells to the lymph nodes, so concomitant downregulation of CD62L and
upregulation of CD44 allow activated T cells to leave lymph nodes and go to sites of
inflammation. T cells that remain CD62Lhi and CD44lo after activation may have
difficulty trafficking to other tissues and remain circulating through the secondary
lymphoid tissues. However, because CARMA1-/- T cells have defective activation and
effector function, they would likely be unable to efficiently clear pathogens at a site of
infection even if they trafficked normally. Thus, our results show that T cell migration
and effector function are jointly controlled by CARMA1, resulting in defective T cell
responses.
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Because CARMA1-/- T cells have impaired activation, and we have shown they have
defective regulation of the expression of motility markers, we hypothesized that
CARMA1-/- T cells would show defective motility compared with WT T cells. To our
surprise, CARMA1-/- T cells moved at a higher velocity than WT T cells (Fig 4). These
results indicate that CARMA1 actually acts as a negative regulator to control the speed of
activated T cells when they are migrating as defects in CARMA1 result in higher
motility. One possible mechanism by which CARMA1 might hinder the motility of T
cells is through regulation of the actin or microtubule networks within the T cell. This
could be through localization of the actin and microtubules or associated proteins. ERM
proteins are actin regulatory proteins that can bind to actin through their C-terminal
domains and to membrane bound proteins through their N-terminal domains (Arpin,
Chirivino, Naba, & Zwaenepoel, 2011). ERM proteins must be activated before they can
bind actin or other proteins; in T cells PKCθ has been shown to phosphorylate and
activate moesin (Pietromonaco et al., 1998). ERM proteins have been shown localize to
the uropod in motile cells, and to bind to CD44, CD43, and ICAM-2, as well as ICAM-1
and ICAM-3 (Serrador et al., 1997; Yonemura et al., 1998). The association of CD43
with ERM proteins is important for phosphorylation of CD43 and T cell migration
(Cannon et al., 2011). ERM proteins also regulate membrane tension in lymphocytes;
constitutively active ezrin slowed migration and increased the membrane tension in T
cells (Liu et al., 2012).

Our results show that CARMA1 is involved in regulating the localization of ERM
proteins in motile T cells; fewer of the CARMA1-/- T cells had moesin localized to the
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uropod. Defective localization could decrease the membrane tension in the CARMA1-/- T
cells and lead to faster migration. However, we also saw defective localization in the
PKCθ-/- T cells but we did not see increased migration speed in PKCθ-/- T cells.
Furthermore, we observed defective ERM localization in naïve PKCθ-/- and CARMA1-/T cells, where there was no difference in migration speed between WT and PKCθ-/- or
CARMA1-/- T cells. Therefore it is unlikely that mislocalization of ERM proteins alone
is the cause of the increased speed in the CARMA1-/- T cells. One potential mechanism
for the enhanced motility seen in CARMA1-/- T cells is via regulation of myosin-IIA
(myoIIA), a motor protein important for cell motility (Even-ram et al., 2007). T cells
have been described to move along a substrate in two ways: “walking” that is dependent
mainly on myoIIA, and “sliding” that is mainly dependent on integrins; it was shown that
making the myoIIA dependent movement dominant lead to the T cells moving faster
(Jacobelli, Bennett, Pandurangi, Tooley, & Krummel, 2009). Therefore one potential
explanation for enhanced motility of CARMA1-/- T cells is through greater reliance on
myoIIA, leading to more rapid motility seen in CARMA1-/- T cells.

Our results show that CARMA1 regulates T cell motility in a 2D environment. The
physiological consequences of the faster migration in CARMA1-/- T cells in vitro are not
completely clear. We coated dishes with ICAM-1 and placed the T cells on this coated
surface in the presence of CCL21, so our experiments only looked at one adhesion
molecule and one chemokine in a 2D environment. This differs from the lymph node
environment in vivo in which there is a 3D network of cells and many different molecules
involved. Different signaling pathways are also required for 3D vs. 2D environments. It
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was shown that inhibition of LIM-kinase 1 by MEK, which then allows cofilin, a protein
involved in actin remodeling, to be dephosphorylated, was required for optimal migration
in 3D environments but not 2D environments (Klemke, Kramer, Konstandin, Wabnitz, &
Samstag, 2010). However some molecules are known to be important for migration in
both 2D and 3D environments. Myosin-IIA is not only important for 2D migration, it is
also required for migration in 3D environments as myosin-IIA-deficient cells showed
defects in interstitial migration and recirculation, as well as overadherence to HEVs
(Jacobelli et al., 2010). Therefore if the difference we see in the CARMA1-/- T cells is
related to myoIIA, it is likely that this enhanced migration will be recapitulated in vivo in
a 3D environment as well.

Integrins also play different roles in different environments. Integrins are important for
strong adhesion of T cells to endothelial cells in blood vessels to allow the T cells to enter
tissue, but in the absence of the shear forces caused by the blood flow, such as within
lymph nodes, it was found that the integrins are not so strongly activated and are less
adhesive (Woolf et al., 2007). Woolf et al. also showed that T cells lacking LFA-1 in WT
mice, or WT T cells in ICAM-1 deficient mice, were still able to migrate within the
lymph nodes, but they migrated more slowly than when LFA-1 and ICAM-1 were both
functional. This indicates that LFA-1/ICAM-1 interactions are less important for
migration within lymph nodes, but still play a role. In our in vitro migration assay we did
not introduce a shear force to the cells, so the role of LFA-1 in our assay may be similar
to that in vivo.
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Our assay involved activated T cells, and it is possible that faster migration would be
beneficial for getting Teff cells to the site of infection more quickly. However, the
increased speed may also inhibit maximal T cell function in vivo. Increased migration
speed might make it more difficult to detect and interact with antigen. Not a lot of
studies have been done looking at CARMA1's role in infections, but enhanced migration
by CARMA1-/- T cells may compensate for defective activation.

It is known that naïve T cells do not adhere and migrate well on ICAM-1 without CCL21
signaling through CCR7 (Stachowiak et al., 2006) and we have seen this in our own
experiments as well (data not shown). We have shown that activated T cells are not as
strictly dependent on CCL21 as naïve T cells because activated T cells are still able to
adhere to the ICAM-1 and migrate in the absence of CCL21. However, WT, CARMA1-/-,
and PKCθ-/- T cells all lose speed in the absence of CCL21 or GPCR signaling when T
cells are inhibited with pertussis toxin. The WT T cells migrated at a similar speed in the
absence of CCL21 as with GPCR inhibition, indicating that CCR7 is likely the main
chemokine receptor used for activated T cell motility in WT T cells. Activated PKCθ-/- T
cells also showed a similar reliance on CCR7 as the main chemokine receptor it uses for
migration, as both absence of CCL21 and PTX treatment led to decreased motility.

The activated CARMA1-/- T cells also had a similar decrease in speed with lack of
CCL21 and with Ptx treatment, indicating a partial reliance on CCR7 signaling for
motility. However, even with Ptx treatment, which inhibits all GPCR signaling through
the Gi subunit, including all chemokine signaling, the CARMA1-/- T cells migrated at a
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greater speed than the similarly treated WT T cells. This indicates that the increased
speed that we see in the activated CARMA1-/- T cells is not due solely to chemokine
signaling, and the speed of the T cells is likely increased by some other mechanism, such
as defective regulation of cytoskeleton or associated proteins, as discussed above.

Our data show that CARMA1 regulates T cell migration in a PKCθ-independent manner
in regulation of CD62L and CD44 expression and motility in a 2D environment.
However, we found that both CARMA1 and PKCθ can regulate the localization of ERM
proteins. We saw reduced localization of ERM proteins in both PKCθ-/- T cells and
CARMA1-/- T cells, which suggests that the localization of ERM proteins is mediated by
a pathway involving both PKCθ and CARMA1. However we only saw significantly
reduced localization of p-ERM in the PKCθ-/- T cells and not in the CARMA1-/- T cells.
One possible explanation is the fact that PKCθ directly phosphorylates ERM proteins and
so in the absence of PKCθ there may be much less total p-ERM levels. While we saw
defective localization of ERM proteins in naïve PKCθ-/- and CARMA1-/- T cells, we saw
no difference in the migration of either naïve CARMA1-/- or PKCθ-/- T cells compared to
WT. This result was surprising as we would expect an effect on migration because the
ERM proteins are important for actin regulation. Our in vitro migration assay only looks
at 2D migration on ICAM so it is possible that not all defects will be apparent. In a 3D
environment, T cells have to move through tight spaces in order to get to tissue as well as
migrate through tissues, and defective localization of ERM proteins could lead to a defect
in cytoskeletal rearrangement that could make it more difficult to move through these
spaces.
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2. The role of PKCθ in immunity to Francisella tularensis
The effectiveness of a T cell response to an infection depends on multiple factors,
including migration of T cells to sites of infection, proliferation of the T cells, and
differentiation of the T cells into effector cells that are able to respond to the pathogen
when they arrive at the infection. If T cells have defects in any of these functions, the
effectiveness of the immune response may be reduced. However, the specific molecules
required for an effective immune response to many infections is not well understood.
PKCθ has been shown to be involved in signaling that leads to proliferation, as well as
migration and differentiation, and is important to varying degrees in different types of
infection. In this study we investigated the role of PKCθ in immunity to the intracellular
bacteria Francisella tularensis.

Signaling downstream of TCR activation leads to activation of many transcription
factors, including AP-1 and NF-κB, to regulate proliferation, apoptosis, cytokine
production, and T cell differentiation, which all contribute to mounting an effective
immune response to a pathogen. Activated T cells must differentiate into effector T cells
that are able to respond effectively to the infection. CD8+ T cells become cytotoxic T
cells (CTLs) that can directly destroy an infected cell. CD4+ T cells are more diverse;
they can differentiate into one of many lineages of T helper (Th) cells, each of which is
effective against specific types of pathogens. Th lineages include Th1, Th2, and Th17
cells. Th1 cells produce IFNγ, and are important for defense against viruses and
intracellular pathogens, while Th2 cells produce IL-4, IL-5, and IL-13, and are important
for immunity to extracellular parasites and are responsible for allergic inflammatory
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responses (Liao, Lin, & Leonard, 2011). Th17 cells produce IL-17A and IL-22 and they
participate in immunity to bacteria and fungi, and they are also involved in autoimmune
diseases (Liao et al., 2011). Th cell differentiation depends on many factors, with the
major determinant being specific cytokines present during initial T cell activation. Th1
differentiation is largely induced by IL-12 and IFNγ, while Th2 differentiation is induced
by IL-2 and IL-4, and Th17 differentiation is induced by TGFβ, IL-6, and IL-21 (Zhu,
Yamane, & Paul, 2010).

IL-2 plays an important role in T cell differentiation. IL-2 is involved in promoting CD8+
differentiation into effector and memory CTLs (Liao et al., 2011). IL-2 is also crucial for
Th2 and Th1 differentiation; it activates STAT5 which increases IL-4 production (CoteSierra et al., 2004), and IL-2 also contributes to Th1 differentiation by inducing IFNγ
production (Liao et al., 2011). As discussed earlier, PKCθ is involved in the signaling
that leads to activation of AP-1 and NF-κB, transcription factors that activate many
genes, including the IL-2 gene. PKCθ deficient T cells have been shown to have reduced
IL-2 production (Sun et al., 2000).

Multiple studies have shown that importance of PKCθ varies for different types of T cell
responses. PKCθ is important for Th2 and Th17 responses, and is involved in IFNγ
production, but is largely not required for Th1 or cytotoxic CD8+ T cell responses.

The role of PKCθ in Francisella tularensis infection was previously unknown, but most
studies had shown that PKCθ was required for IFNγ production and Th1 immunity. F.
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tularensis is an intracellular bacterium that infects macrophages primarily, and so a Th1
response is required to help kill infected cells and clear the infection. Thus, we had
hypothesized that PKCθ would likely be required for an effective immune response
against F. tularensis. However, we found that PKCθ was not only not required for
immunity against F. tularensis, but in fact PKCθ deficiency actually allowed the mice to
survive longer following a lethal dose of LVS for WT mice. We saw the same trend in a
lower dose of LVS, with PKCθ-/- mice showing higher survival than WT mice.

From our preliminary findings, we have some clues as to what may be leading to the
increased survival in the PKCθ-/- mice. As T cells have been previously shown to be
critical to mediate immunity against F. tularensis, we analyzed different T cell types in
infected WT and PKCθ-/- mice. Specifically, we determined the number of CD4+, CD8+,
and CD4- CD8- T cells in infected organs. We found that the percentage of T cells that
were CD4+ was decreased in the lungs, liver, and spleen of infected PKCθ-/- mice
compared to infected WT mice, and that there was an increase in the percentage of CD4CD8- T cells in the lungs, liver and spleen of infected PKCθ-/- mice. These results
suggest that one potential mechanism for protection in PKCθ-/- mice against F. tularensis
infection is an increase in CD4-CD8- T cells in the infected organs.

However, because we only looked at CD3, CD4, and CD8, we don't have more specific
information on what kind of T cells the CD4- CD8- T cells are. We know that mice
without CD4+ or CD8+ T cells are still able to control an infection with F. tularensis (J W
Conlan, Sjöstedt, & North, 1994). Two likely candidates are either γδ+ T cells or the
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CD4− CD8− NK1.1− TCRαβ+ Thy1.2+ “DN” T cells, which have both been shown to play
a role in the immune response to F. tularensis. Our results showing that activated PKCθ/-

T cells have an increased population of CD4- CD8- T cells, and the increase in CD4-

CD8- T cells in the infected organs of PKCθ-/- mice indicate that this population is
potentially an important component contributing to the increased survival of the PKCθ-/mice. One possibility is that the CD4-CD8- population are γδ T cells which would
increase protection. Human γδ+ T cells have been shown to control F. tularensis growth
in vitro, and expansion of human γδ+ T cells was shown to be triggered by
phosphoantigens from F. tularensis in vivo (Poquet et al., 1998; Rowland et al., 2012).
γδ+ T cells also have been shown to play an important role in other infections, and are
able to respond to an infection both earlier and later than the αβ+ T cell response (Carding
& Egan, 2002). In response to infection with Listeria monocytogenes, another
intracellular bacterium, the γδ+ T cells were shown to respond early in the infection, at
only 3 days after infection during the innate immune response, helping to activate NK
cells and also to promote T helper differentiation (Ferrick et al., 1995; Ladel, Blum, &
Kaufmann, 1996). In another study with L. monocytogenes, it was shown that γδ+ T cells
play a role late in the infection, by helping to control inflammation and prevent excessive
tissue damage (Fu et al., 1994). If the increased numbers of CD4- CD8- T cells we see in
the organs of our LVS infected PKCθ-/- mice are γδ+ T cells, then a boost in the innate
response and a reduction of later inflammation could help explain the survival of these
mice over the WT mice.

Alternatively, the CD3+CD4-CD8- T cell pool we see in the PKCθ-/- T cells may belong to
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the unique and rare CD4− CD8− NK1.1− TCRαβ+ Thy1.2+ “DN” T cells which have been
shown to control F. tularensis growth in vitro and control infection in vivo (Cowley et al.,
2005). DN T cells are a significant portion of the T cells found in the infected tissues,
and produce IFNγ, IL-17A, and TNF-α which all help control the infection (Cowley &
Elkins, 2003; Cowley et al., 2010). While they produce the same cytokines as the CD4+
and CD8+ T cells, DN T cells alone cannot completely clear the infection, so there must
be a difference in their mechanisms for controlling infection with LVS (Yee et al., 1996).
Thus, it is possible that in the infected PKCθ-/- animals which survive, the prolonged
survival is merely enhanced control of F. tularensis infection rather than actual clearance.
While we saw survival up to 40 days of infection, which indicates long term survival, we
have not yet analyzed whether the PKCθ-/- mice might still harbor LVS after prolonged
survival.

The mechanism by which these DN T cells develop and how they affect bacterial control
remains to be determined. PKCθ is not required for T cell development in the thymus
(Altman & Villalba, 2003), and naïve PKCθ-/- T cells taken from PKCθ-/- lymph nodes
were found to have similar populations of CD4+, CD8+, and double positive (CD4+CD8+)
and double negative (CD4-CD8-) T cell populations as WT T cells. Therefore it is likely
that any change in the ratios of the different T cell populations occurs upon T cell
activation and differentiation, and our results show that PKCθ-/- T cells appear to develop
an increased number of CD4-CD8- T cells upon activation (Chapter 3, Figure 21). How
PKCθ may contribute to the development of CD4-CD8- T cells upon activation remains
unknown.
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With the increased CD4-CD8- T cell population, we see a decrease in CD4+ T cells in
infected PKCθ-/- mice compared with infected WT mice. One possible explanation for
this is that the CD4+ T cells lose the CD4 marker and become CD4- CD8- T cells,
however, this does not seem likely as there is no evidence of this type of development
occurring in other models. A second possible explanation is that the proliferation of the
CD4+ T cells or migration of CD4+ T cells is decreased in the PKCθ-/- mice. We know
that PKCθ-/- T cells have defects in proliferation following TCR activation as a result of
PKCθ's role in NF-κB activation (Altman & Villalba, 2003), so it is likely that
proliferation of CD4+ T cells was reduced in the infected PKCθ-/- mice. Interestingly, we
do not see any change in the ratios of the CD4+ and CD4-CD8- T cell populations in the
non-draining lymph nodes, only in the sites of infection, suggesting the CD4- CD8- T
cells may be receiving signals to increase their proliferation within the infected organs.

Alternatively, it is also possible that there is a change in the rate of migration of the
PKCθ-/- T cells compared to WT in response to LVS infection. PKCθ-/- T cells may have
enhanced migration to infection sites, or may be less efficient at migration out of
infection sites and thus, provide enhanced protection for longer at the infection site. In
Part 1, we showed that polarized PKCθ-/- T cells had mislocalization of ERM proteins.
Because ERM proteins are important for regulation of the actin cytoskeleton, this could
affect migration of the T cells. While we did not see any changes in migration of the
PKCθ-/- T cells compared to the WT T cells on ICAM-1 in vitro, the ERM localization
defect may cause changes in migration of the T cells in vivo. We also saw no defect in
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activated PKCθ-/- T cells of the cell surface expression of two migration markers, CD44
and CD62L, but others have seen defective upregulation of LFA-1 in response to an
infection that resulted in reduced migration to the site of infection (Ohayon et al., 2010).
It is also possible that PKCθ may regulate the expression of additional migration factors
that can control the number of T cells at an inflammatory site, such as PSGL1 or other
proteins that mediate T cell migration to inflammatory sites. Because we have seen
differences in the sub-populations of T cells within the sites of infection between infected
WT and PKCθ-/- mice, it may also be that PKCθ-deficiency affects the migration of some
of these populations differently, in a way that is beneficial to the host.

We have shown that PKCθ deficiency protects mice from lethal LVS infection, and also
show preliminary data that indicates that PKCθ deficiency increases the CD4- CD8- T cell
population upon activation and in LVS infected organs, which may enhance immunity
against F. tularensis. Further investigation of LVS infection in PKCθ-/- mice will be
required to determine the precise role of PKCθ in T cell responses upon infection and the
role of the CD4- CD8- T cell population in the response. Future studies would include
determining the infiltration of immune cells at earlier time points to assess whether PKCθ
affects T cell migration or activation. Production of cytokines should also be analyzed in
the infected WT and PKCθ-/- mice to determine whether PKCθ might change cytokine
profile to increase survival of the PKCθ-/- mice.

In conclusion, we have shown a novel role for CARMA1 in regulating T cell migration,
and we have shown that CARMA1 does this in a PKCθ independent manner. Further
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studies may help determine the pathways through which CARMA1 acts, and determine
other molecules that may be involved in PKCθ independent signaling pathways. Future
studies would include determining what CARMA1 may be acting on to regulate the
speed of activated T cells, such as Bcl10 and MALT1, which have both been shown to be
in a complex with CARMA1. Further investigation of the effects of CARMA1 and PKCθ
on T cell migration in vivo would provide valuable insight into the potential effect of
these proteins in protection against infection such as Francisella tularensis. Our studies
show that specific signaling molecules regulate discrete T cell functions such as
proliferation and migration, leading to differential effects on T cell immunity against
pathogens.
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